<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Acta Neuropathol Commun</journal-id>
<journal-id journal-id-type="iso-abbrev">Acta Neuropathol Commun</journal-id>
<journal-title-group>
<journal-title>Acta Neuropathologica Communications</journal-title>
</journal-title-group>
<issn pub-type="epub">2051-5960</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30922385</article-id>
<article-id pub-id-type="pmc">6440020</article-id>
<article-id pub-id-type="publisher-id">674</article-id>
<article-id pub-id-type="doi">10.1186/s40478-019-0674-x</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcriptomopathies of pre- and post-symptomatic frontotemporal dementia-like mice with TDP-43 depletion in forebrain neurons</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wu</surname>
<given-names>Lien-Szu</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Cheng</surname>
<given-names>Wei-Cheng</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Chia-Ying</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Ming-Che</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yi-Chi</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tseng</surname>
<given-names>Yu-Hsiang</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chuang</surname>
<given-names>Trees-Juen</given-names>
</name>
<address>
<email>trees@gate.sinica.edu.tw</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Shen</surname>
<given-names>C.-K. James</given-names>
</name>
<address>
<phone>011-886-2-27824188</phone>
<email>ckshen@gate.sinica.edu.tw</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2287 1366</institution-id><institution-id institution-id-type="GRID">grid.28665.3f</institution-id><institution>Institute of Molecular Biology, </institution><institution>Academia Sinica, </institution></institution-wrap>Nankang, Taipei, 115 Taiwan, Republic of China </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2287 1366</institution-id><institution-id institution-id-type="GRID">grid.28665.3f</institution-id><institution>Genomics Research Center, </institution><institution>Academia Sinica, </institution></institution-wrap>Taipei, Taiwan </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2287 1366</institution-id><institution-id institution-id-type="GRID">grid.28665.3f</institution-id><institution>Research Center for Environmental Changes, </institution><institution>Academia Sinica, </institution></institution-wrap>Taipei, Taiwan, Republic of China </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>29</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>29</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>7</volume>
<elocation-id>50</elocation-id>
<history>
<date date-type="received">
<day>2</day>
<month>2</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>4</day>
<month>2</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">TAR DNA-binding protein <bold>(</bold>TDP-43) is a ubiquitously expressed nuclear protein, which participates in a number of cellular processes and has been identified as the major pathological factor in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Here we constructed a conditional TDP-43 mouse with depletion of TDP-43 in the mouse forebrain and find that the mice exhibit a whole spectrum of age-dependent frontotemporal dementia-like behaviour abnormalities including perturbation of social behaviour, development of dementia-like behaviour, changes of activities of daily living, and memory loss at a later stage of life. These variations are accompanied with inflammation, neurodegeneration, and abnormal synaptic plasticity of the mouse CA1 neurons. Importantly, analysis of the cortical RNA transcripts of the conditional knockout mice at the pre−/post-symptomatic stages and the corresponding wild type mice reveals age-dependent alterations in the expression levels and RNA processing patterns of a set of genes closely associated with inflammation, social behaviour, synaptic plasticity, and neuron survival. This study not only supports the scenario that loss-of-function of TDP-43 in mice may recapitulate key behaviour features of the FTLD diseases, but also provides a list of TDP-43 target genes/transcript isoforms useful for future therapeutic research.</p>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1186/s40478-019-0674-x) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Circular RNAs/ frontotemporal lobar degeneration/ loss-of-function/ Mis-processing/TDP-43</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001868</institution-id>
<institution>National Science Council</institution>
</institution-wrap>
</funding-source>
<award-id>MOST 107-2321-B-001-016</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001869</institution-id>
<institution>Academia Sinica</institution>
</institution-wrap>
</funding-source>
<award-id>022319</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par2">Frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS) are both incurable and rapidly progressive neurodegenerative diseases of the central nerves system, and they have overlapping spectra of pathogenic features [<xref ref-type="bibr" rid="CR75">75</xref>]. While patients with FTLD exhibit a range of progressive changes in language dysfunction, behavioural abnormality, personality change, memory deficit, or motor neuron dysfunction [<xref ref-type="bibr" rid="CR71">71</xref>], muscle weakness and motor neuron degeneration are the predominant symptoms of ALS [<xref ref-type="bibr" rid="CR76">76</xref>]. The cytoplasmic ubiquitinated inclusions (UBIs) consisting of relocated nuclear TDP-43 protein is a common pathological characteristic observed in 50% of FTLD (FTLD-TDP) and 95% of ALS (ALS-TDP) [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR54">54</xref>].</p>
<p id="Par3">TDP-43, or TAR DNA-binding protein-43 [<xref ref-type="bibr" rid="CR55">55</xref>], encoded by the highly conserved <italic>Tardbp</italic> gene [<xref ref-type="bibr" rid="CR82">82</xref>] is a RNA-binding protein involved in transcriptional repression, pre-mRNA splicing, and translation [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]. TDP-43 in the diseased cells of the patients’ brains of FTLD-TDP or spinal cords of ALS-TDP is characterized with abnormal ubiquitination, hyperphosphorylation, and enhanced cleavage to generate the 25 kDa and 35 kDa C-terminal fragments (TDP-25 and TDP-35) [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. Furthermore, TDP-43 is partially or completely cleared from the nuclei of neuronal and/ or glial cells containing cytosolic TDP-43 (+) UBIs [<xref ref-type="bibr" rid="CR53">53</xref>].</p>
<p id="Par4">Mouse models with transgenic overexpression of TDP-43, knock-out/ knock-down of <italic>Tardbp</italic> gene expression often serve as the biological system for exploring the physiological functions of TDP-43 and its pathogenic roles in neurodegeneration [<xref ref-type="bibr" rid="CR75">75</xref>]<italic>.</italic> Most of the transgenic TDP-43 mouse lines overexpress human TDP-43, wild type or mutants, under the control of pan-neuronal promoter, and the resulting phenotypes appear to be primarily relevant to ALS [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. Studies have engineered the mice to overexpress wild-type TDP-43 or induced depletion of TDP-43 in the forebrain region, which sufficed to cause neurodegeneration of brain [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. However, the pathological features of most of these various mouse models do not follow a pattern of adult-onset diseases. Furthermore, the analysis of their behavioural deficits has been predominantly based on motor function or Alzheimer disease-related tests [<xref ref-type="bibr" rid="CR75">75</xref>]. On the other hand, FTLD patients with behavioural abnormalities (behavioural variant frontotemporal dementia, bvFTLD) present predominantly with persistent changes in behaviour and social functioning, which manifest in disinhibition, apathy, altered food preferences and executive deficits. Also, impairment of motor function and hippocampal-dependent learning/memory are rare in early stage bvFTLD [<xref ref-type="bibr" rid="CR61">61</xref>].</p>
<p id="Par5">Moreover, the relative contributions of loss-of-function and gain-of-cytotoxicity to the neurodegeneration in FTLD-TDP or ALS-TDP remain to be better defined [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]. The physiological functions of TDP-43 in different mammalian tissues also await further investigation. Our previous results have shown that TDP-43 is important for early mouse embryo development [<xref ref-type="bibr" rid="CR88">88</xref>] and that loss-of-TDP-43 function in spinal motor neurons can generate many of the ALS-TDP phenotypes [<xref ref-type="bibr" rid="CR89">89</xref>]. To explore the normal physiological function of TDP-43 and examine whether depletion of TDP-43 expression in brain could cause the neurodegeneration in FTLD-TDP, we have utilized the <italic>Tardbp</italic><sup>lx</sup> mouse line [<xref ref-type="bibr" rid="CR88">88</xref>] and generated conditional knockout mice (TDP-43 cKO) with forebrain-specific depletion of TDP-43. We find that these mice exhibit a range of pathological phenotypes in striking similarity to FTLD. We further generate high-throughput RNA sequencing (RNA-seq) data from pre- and post-symptomatic TDP-43 cKO mice and the corresponding wild type mice, and show that some of these pathological phenotypes correlate well with specific changes of the gene expression profile in the forebrain upon depletion of TDP-43.</p>
</sec>
<sec id="Sec2">
<title>Results</title>
<sec id="Sec3">
<title>Generation of mouse lines with <italic>αCaMKII</italic> promoter-directed depletion of forebrain TDP-43</title>
<p id="Par6">To understand the pathophysiological role of TDP-43 in adult brain, we generated conditional knock-out mice with forebrain-specific deletion of <italic>Tardbp</italic> gene by crossing <italic>Tardbp</italic> floxP mice with α<italic>CaMKII</italic>-Cre mice (T29–1 line) [<xref ref-type="bibr" rid="CR88">88</xref>], the latter of which express α<italic>CaMKII</italic>-Cre only in neurons of the adult mouse brain [<xref ref-type="bibr" rid="CR79">79</xref>]. Mice with <italic>Tardbp</italic><sup><italic>flox/flox</italic>, Cre+</sup> alleles, referred to as TDP-43 cKO, were born at normal Mendelian ratios and appeared indistinguishable from their wild type littermate controls (<italic>Tardbp</italic><sup><italic>flox/flox</italic>, Cre-</sup>, referred to as Ctrl) at birth. As expected, immunohistochemistry analysis of the TDP-43 cKO mice at 2 months of age confirmed the deletion of <italic>Tardbp</italic> gene and consequent depletion of TDP-43 expression in the forebrain region, in particular in the CA1 pyramidal cell layer of the hippocampus (Fig. <xref ref-type="fig" rid="Fig1">1</xref>a and Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2a). Western blot analysis of TDP-43 expression in the TDP-43 cKO mice at 3 and 12 months of age also supported that depletion of TDP-43 was restricted to the cortex and hippocampus (upper panels of Fig. <xref ref-type="fig" rid="Fig1">1</xref>b and c), but not in cerebellum and spinal cord (lower panels of Fig. <xref ref-type="fig" rid="Fig1">1</xref>b). 50% of TDP-43 cKO mice died around the age of 17 months, approximately 12 months shorter than the Ctrl mice (Fig. <xref ref-type="fig" rid="Fig1">1</xref>d). Collectively, the results in Fig. <xref ref-type="fig" rid="Fig1">1</xref> demonstrate the successful establishment of a mouse model with postnatal depletion of TDP-43 in the forebrain and the shortened life span of TDP-43 cKO mice in comparison to their wild type littermate controls.<fig id="Fig1"><label>Fig. 1</label><caption><p>A mouse model (TDP-43 cKO) with <italic>αCaMKII</italic> promoter-directed depletion of TDP-43 in forebrain neurons. <bold>a</bold> Immunofluorescence staining analysis of brain sections from a cohort of 2-month-old Ctrl and TDP-43 cKO mice (TDP-43, magenta; NeuN, green; DAPI, blue). Cortex, CTX; cornu ammonis area, CA; dentate gyrus, DG. Scale bar represents 100 μm. <bold>b</bold> Western blotting analysis of the relative expression levels of TDP-43 and GFAP proteins in different tissues including cortex, hippocampus, cerebellum, and spinal cord of 3- and 12-month-old TDP-43 cKO mice and Ctrls. Note that ~ 50% reduction of TDP-43 protein level in the hippocampus and ~ 60% reduction of TDP-43 protein level in the cortex, but not in the cerebellum, and spinal cord in TDP-43 cKO mice. The Western blot patterns are exemplified in <bold>b</bold>, and the results of statistical analysis by unpaired student’s t test are shown in <bold>c</bold>
<italic>P &lt;</italic> 0.05 was considered significant. Data are represented as the average of 4 mice per group, with error bars reported as SEM. <bold>d</bold> Kaplan-Meyer survival curves of TDP-43 cKO mice and the Ctrls. Note the significantly shortened lifespan of TDP-43 cKO mice (<italic>P</italic> &lt; 0.0001, log-rank Mantel-Cox test). The mean survival days are 28.8 months for the Ctrl mice and 17.2 months for the TDP-43 cKO mice</p></caption><graphic id="MO1" xlink:href="40478_2019_674_Fig1_HTML"></graphic></fig></p>
</sec>
<sec id="Sec4">
<title>Perturbation of social behaviour and development of dementia-like behaviour in TDP-43 cKO mice at the early stage of behaviour variations</title>
<p id="Par7">TDP-43 has been identified as the major pathological protein in 50% of FTLD patients [<xref ref-type="bibr" rid="CR80">80</xref>] and FTLD is characterized by a preponderance of abnormalities in social behaviour rather than memory, especially in the early stages of the disease [<xref ref-type="bibr" rid="CR61">61</xref>]. Hence, we tested the social interaction behaviour of TDP-43 cKO mice by the three-chamber sociability and social novelty test [<xref ref-type="bibr" rid="CR38">38</xref>] at 3, 6, and 12 months of age. In the test for social preference (session I), unlike the Ctrls, 12-month-old TDP-43 cKO mice showed no preference for their conspecific (stranger 1) over the object by spending similar time investigating the empty cage and stranger 1 (upper panels, Fig. <xref ref-type="fig" rid="Fig2">2</xref>a). In the test for preference of social novelty and social recognition (session II), either 6- or 12-month-old TDP-43 cKO mice failed to demonstrate a preference for unfamiliar mouse (stranger 2) compared with the familiar one (stranger 1) (lower panels, Fig. <xref ref-type="fig" rid="Fig2">2</xref>a). TDP-43 cKO mice exhibited a progressive decline in their capability of social interaction as observed among the bvFTLD patients.<fig id="Fig2"><label>Fig. 2</label><caption><p>Progressively dismissing of social recognition and development of behaviour variants of the TDP-43 cKO mice. <bold>a</bold> For social interaction test (Session 1), the mean lengths of time (±SEM) the mouse spent in the chamber with the stranger (“Stranger 1”) and in the opposite chamber (“Empty”) are compared in the histograms. For social memory and novelty test (Session II), the mean durations of time (±SEM) in the chamber with the unfamiliar mouse from the sociability phase (“Stranger 1”) and in the opposite chamber with a new unfamiliar mouse (“Stranger 2”) are compared in the histograms. Statistical analysis was done by Two-way ANOVA (<italic>N</italic> = 8/group) with error bars reported as SEM, <italic>P &lt;</italic> 0.05 was considered significant. <bold>b</bold> Light/ dark box test. The latencies of mouse entering the dark box for the first time, the light/dark transition periods, and durations of mouse in the light box were measured for mice of the ages of 3 months, 6 months, and 12 months, respectively, and statistical analysis was done by unpaired t test (<italic>N</italic> = 12/group) with error bars reported as SEM, <italic>P &lt;</italic> 0.05 was considered significant. <bold>c</bold> Morris water maze tests. In the hidden platform test (left panels), the 12-month-old TDP-43 cKO mice had longer latencies to escape onto the hidden platform. Statistical analysis was done in curves by Two way ANOVA (N = 8/group) with error bars reported as SEM, <italic>P &lt;</italic> 0.05 was considered significant. In the probe trial on the 8th session (right panels), the 12-month-old TDP-43 cKO mice traveled crossed the target, where the hidden platform was previously placed, significantly less times than the Ctrl mice. Statistical analysis was done in the histograms by unpaired t test with error bars reported as SEM. <bold>d</bold> Accelerated rotarod test. Ctrl and TDP-43 cKO mice were trained at the age of 2 months and then tested monthly on the accelerated rotarod (<italic>N</italic> = 11~14 in Ctrl group; <italic>N</italic> = 6~9 in TDP-43 cKO group). The histograms of latencies before falling showed that at 12 months of age, the TDP-43 cKO mice failed to memorize the rotarod running but re-learned right after the second day of training. At the end stage, e.g. older than 16 months, the TDP-43 cKO mice were unable to re-learn the rotarod running. Statistical analysis was done by unpaired t test with error bars reported as SEM, <italic>P &lt;</italic> 0.05 was considered significant</p></caption><graphic id="MO2" xlink:href="40478_2019_674_Fig2_HTML"></graphic></fig></p>
<p id="Par8">The light/dark box test [<xref ref-type="bibr" rid="CR20">20</xref>] was used to assess the anxiety-like behaviour [<xref ref-type="bibr" rid="CR74">74</xref>] of the TDP-43 cKO mice. TDP-43 cKO mice at 12-month-old showed an increased latency in moving from the brightly lit area to the dark area, an increase in time spent in the light area, and markedly decreased crossings between light and dark area in comparison to the Ctrl mice (Fig. <xref ref-type="fig" rid="Fig2">2</xref>b). These data suggest that depletion of TDP-43 in mice lead to develop the dementia-like behaviour [<xref ref-type="bibr" rid="CR43">43</xref>].</p>
</sec>
<sec id="Sec5">
<title>Sequential impairment of learning/ memory capability and locomotor function in TDP-43 cKO mice at later stage of behaviour variations</title>
<p id="Par9">FTLD patients usually did not display cognitive deficits until later stage of the disease [<xref ref-type="bibr" rid="CR52">52</xref>]. We used the Morris Water Maze to examine the hippocampus-dependent learning/memory, including acquisition of spatial memory and long-term spatial memory [<xref ref-type="bibr" rid="CR81">81</xref>] of TDP-43 cKO mice. As shown in Fig. <xref ref-type="fig" rid="Fig2">2</xref>c, TDP-43 cKO mice show severe learning/memory impairment at the age of 12 months (left panels of Fig. <xref ref-type="fig" rid="Fig2">2</xref>c). In the probe trial, only the 12-month-old TDP-43 cKO mice exhibited a significant smaller numbers of target platform crossings in comparison to the age-matched Ctrls (right panels of Fig. <xref ref-type="fig" rid="Fig2">2</xref>c). Overall, the progressive dementia of the TDP-43 cKO mice strongly suggests that the functional requirement of TDP-43 in learning/ memory at later stage of life [<xref ref-type="bibr" rid="CR43">43</xref>].</p>
<p id="Par10">Defective motor coordination developed in the late stages of a proportion of patients with FTLD [<xref ref-type="bibr" rid="CR11">11</xref>]. We thus examined the locomotor activity of TDP-43 cKO mice using the accelerated rotarod tests. While no difference in motor performance could be found between Ctrl and TDP-43 cKO mice before the age of 12 months, older TDP-43 cKO mice exhibited reduced motor performance on the 1st day of test (Fig. <xref ref-type="fig" rid="Fig2">2</xref>d). Interestingly, their performance would become better on the 2nd day of test, and there was no difference between the TDP-43 cKO and Ctrl mice on the 3rd day of test (Fig. <xref ref-type="fig" rid="Fig2">2</xref>d). This result suggested that the impairment of rotarod performance of the TDP-43 cKO mice was mainly due to their memory loss. They barely remembered how to perform on the rotarod, but could re-learn after 1st day of test. However, while the motor deficiency was also observed after 16 months of age, it could not be reversed on the 2nd or 3rd day of test (Fig. <xref ref-type="fig" rid="Fig2">2</xref>d). The massive degeneration of cortex might result in the reduced motor performance after 16 months of age which the TDP-43 cKO mice loss their memory and learning ability to perform rotartod. Neverless, the above data show that in addition to severe memory loss developed after 12 months of age, TDP-43 cKO mice also exhibit motor dysfunction after the age of 16 months. This pattern is in interesting parallel to the sequential impairment of these two neuronal functions during FTLD pathogenesis [<xref ref-type="bibr" rid="CR75">75</xref>].</p>
</sec>
<sec id="Sec6">
<title>Progressively changes of nesting behaviour and eating habits in TDP-43 cKO mice</title>
<p id="Par11">Beside cognitive dysfunction, patients with dementia including FTLD also exhibit decreased activities of daily living (ADL). We analyzed the changes of eating habits in TDP-43 cKO mice and found reduced food intake by the aged TDP-43 cKO mice (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1c) but not in younger ones (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1a and S1b). We also compared nest construction scores [<xref ref-type="bibr" rid="CR21">21</xref>] between the Ctrl and TDP-43 cKO mice. There was a significant difference in the nesting behaviour between TDP-43 cKO and Ctrls at 12 months of age (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1d). Taken together, these results indicate that accompanying with the dementia phenotype, aged TDP-43 cKO mice also developed a progressive decrease of their ADL.</p>
</sec>
<sec id="Sec7">
<title>Brain atrophy, neuronal loss, and neuronal degeneration of the TDP-43 cKO mice</title>
<p id="Par12">Necropsy examination showed that the 12-month-old TDP-43 cKO mice, but not 3-month-old ones, had a significant reduction of the overall brain size and its weight when compared to age-matched Ctrls, which appeared to be mainly due to a decrease in the size of the cortical areas <bold>(</bold>Fig. <xref ref-type="fig" rid="Fig3">3</xref>a). In parallel, hematoxylin and eosin staining showed aberrant cellular patterns and layering in the cortex of 12-month-old TDP-43 cKO mice (Fig. <xref ref-type="fig" rid="Fig3">3</xref>b and Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2). Also, the thickness of cerebral cortex was reduced and the size of the ventricles was enlarged when compared to the Ctrls (Fig. <xref ref-type="fig" rid="Fig3">3</xref>b and c). These results are indicated that depletion of TDP-43 causes the brain atrophy in mice [<xref ref-type="bibr" rid="CR43">43</xref>].<fig id="Fig3"><label>Fig. 3</label><caption><p>Brain atrophy and reactive astrocytosis in TDP-43 cKO mice. <bold>a</bold> Left, representative photo images of the brains of Ctrl and TDP-43 cKO mice at the ages of 3 months and 12 months. The total brain weights were also determined and compared in histograms on the right. <italic>N</italic> = 4–7 mice per group. Statistical analysis was done by unpaired t test with error bars reported as SEM, <italic>P &lt;</italic> 0.05 was considered significant. <bold>b</bold> Representative histological images of the brain sections of 3- and 12-month-old TDP-43 cKO mice and their littermate Ctrls. More detailed characterizations are presented in Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2. <bold>c</bold> Left panels, Nessie staining images of the forebrain and hippocampus sections from the Ctrl and TDP-43 cKO mice showing marked atrophy at corpus callosum (cc) and ventricle enlargement in the brain of 12-month-old TDP-43 cKO mice compared to Ctrls. The total cortex thickness and corpus callosum thickness were calculated by the length of cortex area and corpus callosum. N = 4 mice per group. Statistical analysis was done by unpaired t test with error bars reported as SEM, <italic>P &lt;</italic> 0.05 was considered significant. <bold>d</bold> Immunohistochemistry staining with anti-GFAP revealing high numbers of GFAP-positive astrocytes in the retrosplenial cortex (RS) region of the cortex and stratum lacunosum-moleculare (SLM) region in the brain of TDP-43 cKO mice</p></caption><graphic id="MO3" xlink:href="40478_2019_674_Fig3_HTML"></graphic></fig></p>
<p id="Par13">Massive neuronal degeneration was observed in the cortex and hippocampus of 12-month-old TDP-43 cKO mice (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2 b-d). In particular, Golgi staining showed that the average length of the dendrites on dendritic stems of the layer V neurons of 12-month-old TDP-43 cKO mice was shorter than that of the control group <bold>(</bold>Fig. <xref ref-type="fig" rid="Fig4">4</xref>a<bold>)</bold>. Morever, the numbers of neuron with the beading or shorter dendrites [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR72">72</xref>] were increased mainly in the layer V pyramidal neuron of TDP-43 cKO mice at the age of 12 months <bold>(</bold>Fig. <xref ref-type="fig" rid="Fig4">4</xref>b and c<bold>)</bold>. Immunofluorescense staining showed that the number of neurofilament H marker (SMI-32)-positive neurons in layer III/ V of retrosplenial cortex (RS), but not those in the somatosensory cortex, decreased in TDP-43 cKO mice (Fig. <xref ref-type="fig" rid="Fig4">4</xref>d). Taken together, there appears to be significant and progressive neuronal degeneration in TDP-43 cKO mice in a selective vulnerability manner, with distinct neuronal populations in different cortical layers compromised by the depletion of TDP-43.<fig id="Fig4"><label>Fig. 4</label><caption><p>Dendritic alternations of neurons in the cortex of aged TDP-43 cKO mice. Golgi staining was used to visualize the neuronal dendrites in the cortex of 3- and 12-month-old TDP-43 cKO mice in comparison to the Ctrl mice. <bold>a</bold> Representative images of the Golgi-staining patterns in the left 2 panels show the obvious morphology changes and dendritic shortening of the cortical neuron of 12-month-old TDP-43 cKO mice in comparison to the Ctrl mice. Scale bar is 500 μm. Quantitative comparison of the dendritic lengths of cortical layer V neurons of TDP-43 cKO and Ctrl mice is shown in the right two diagrams. Note the significant reduction of the average dendritic length in 12-month-old TDP-43 cKO. Statistical analysis was done by unpaired t test with the error bars being SEM. <italic>P &lt;</italic> 0.05 was considered significant. <bold>b</bold> Enlarged views of cortical layer V neurons. Representative images show the cortical dendrites with segmental beading dendrites (arrow heads) and degenerated spines (arrows), respectively. Scale bar is 20 μm. <bold>c</bold> Quantifications of the % of cortical layer V neurons with beading dendrites (left histogram) or shorter dendrites (right histogram). Statistically analyzed by unpaired t test with error bars reported as SEM, <italic>P &lt;</italic> 0.05 was considered significant. Note the markedly increase of abnormal dendrites in TDP-43 cKO mice at the age of 12 months, but not 3 months. <bold>d</bold> Immunofluorescence staining with anti-neurofilament H (SMI-32) (green) showing a marked decrease of the neuron numbers in the cortical layer III/ V of the retrosplenial cortex (RS) of TDP-43 cKO mouse brain but not Ctrls. Enlarged views of RS region are shown in the upper left corner of each image</p></caption><graphic id="MO4" xlink:href="40478_2019_674_Fig4_HTML"></graphic></fig></p>
</sec>
<sec id="Sec8">
<title>Chronic astrocytosis in the forebrain of TDP-43 cKO mice</title>
<p id="Par14">We assessed the astrocyte response during the progressive cortical degeneration describe above. As shown, GFAP-positive astrocytes in the cortical layers and hippocampus of Ctrl mice of different ages were mainly found in the corpus callosum and rarely in the neuronal layers of the cortex (upper panels, Fig. <xref ref-type="fig" rid="Fig3">3</xref>d). Furthermore, their slim morphology suggested a resting state of the astrocytes (upper panels, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3a). In stark contrast, large numbers of tufted enlarged GFAP-positive astrocytes were found in the retrosplenial cortex (RS) and in the stratum lacunosum-moleculare (SLM) region of the hippocampus of TDP-43 cKO mice (lower panels, Fig. <xref ref-type="fig" rid="Fig3">3</xref>d and Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3a) and they progressively increased during aging (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3a and b), coinciding with the progressive thinning of the cortex exemplified in Fig. <xref ref-type="fig" rid="Fig3">3</xref>b. However, no microglia activation was observed at all stages of the Ctrl and TDP-43 cKO mice analyzed (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3c). These results indicated that progressive astrogliosis, but not microgliosis was found in TDP-43 cKO mice which reflecting the neuropathological changes. Taken together, depletion of TDP-43 in the forebrain neurons resulted in a substantial and persisting activation of the astrocytes.</p>
</sec>
<sec id="Sec9">
<title>Impaired synaptic plasticity in TDP-43 cKO mice</title>
<p id="Par15">TDP-43 has been shown to be a modulator of synaptic plasticity in transgenic mouse models of ALS and FTLD [<xref ref-type="bibr" rid="CR30">30</xref>]. We investigated whether depletion of TDP-43 indeed affected the synaptic plasticity by examining the Schaeffecr collateral pathway of TDP-43 cKO mice for synaptic plasticity, long-term potentiation (LTP) and long-term depression (LTD). As shown in Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4, the magnitude of long-term potentiation (LTP) and long-term depression (LTD) in the hippocampal slices from 2-month-old TDP-43 cKO mice was unaffected (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4a and c). At the age of 12 months, LTP in the hippocampus of TDP-43 cKO mice were significantly lower than the Ctrl mice <bold>(</bold>Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4b and c<bold>)</bold>. Alltogether, these results show that depletion of TDP-43 in the forebrain neurons affects the synaptic functions.</p>
</sec>
<sec id="Sec10">
<title>Genome-wide analysis of the neocortex transcriptomes of pre- and post-symptomatic TDP-43 cKO mice in comparison to ctrl mice</title>
<p id="Par16">Transcripts exhibiting alternations of their expression levels or splicing patterns in TDP-43 depleted cells other than cortex have been identified before by RNA-seq analysis [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. However, a transcriptome-wide analysis of the relationship between TDP-43 targeted RNAs and TDP-43 regulated behaviour/phenotypes was lacking. We used paired-end deep sequencing <bold>(see</bold>
<xref ref-type="sec" rid="Sec15"><bold>Materials and Methods</bold></xref><bold>)</bold> to examine the gene expression profiles in the neocortex (the region indicated in the left part of Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2a) of TDP-43 cKO mice and their corresponding littermate controls at both the pre-symptomatic (3-month) and post-symptomatic (12-month) stages. The differential expression analysis (see <xref ref-type="sec" rid="Sec15">Materials and Methods</xref>) revealed 52 and 121 up-/down-regulated genes at the ages of 3 months and 12 months, respectively <bold>(</bold>Fig. <xref ref-type="fig" rid="Fig5">5a</xref>-(i)). Interestingly, the number of the down-regulated genes was much greater in 12-month-old TDP-43 cKO mice than in 3-month-old cKO ones <bold>(</bold>Fig. <xref ref-type="fig" rid="Fig5">5a</xref>-(ii)), in correlation with the progression of the FTLD-like pathological phenotypes of the mutant mice <bold>(</bold>Fig. <xref ref-type="fig" rid="Fig2">2</xref>-<xref ref-type="fig" rid="Fig4">4</xref><bold>)</bold>.<fig id="Fig5"><label>Fig. 5</label><caption><p>Analysis of the impact of mRNA transcriptomes in neocortex of 3- or 12-month-old TDP-43 cKO mice<bold>. a(i),</bold> The numbers of the unchanged, up-regulated, down-regulated, and splicing-changed genes, respectively, in the neocortex of 3- or 12-month-old TDP-43 cKO mice in comparison to the Ctrls. Only gene expression changed with FPKM&gt; 0.2 were considered in the analysis. The numbers in the parentheses are the numbers of the differentially expressed genes in the neocortex of TDP-43 cKO mice at both the ages of 3 months and 12 months in comparison to the Ctrls. (<bold>ii),</bold> Scatter plot showing log<sub>2</sub> fold change of neocortex gene expression of 3-month-old (left panel) and 12-month-old (right panel) TDP-43 cKO mice and control mice, respectively. The red, blue, and gray dots indicate up-regulated (q &lt; 0.05), down-regulated (q &lt; 0.05), and non-significantly changed genes, respectively, in the neocortex of TDP-43 cKO mice. Each dot represents the mean value of data from analysis of triplicate neocortex sample sets. (<bold>iii),</bold> Scatter plot showing the correlation of log<sub>2</sub> fold change of genes altered in the neocortex of TDP-43 cKO mice at 12 months (x axis) and 3 months (y axis) of age. The purple and blue dots indicate neocortex genes the expression levels of which are altered only in 3-month-old TDP-43 cKO mice (40 genes) and only in 12-month-old TDP-43 cKO mice (109 genes), respectively. The 12 neocortex genes deregulated in TDP-43 cKO mice at both ages are indicated by the red dots (12 genes). (<bold>iv),</bold> Heat map representation of the expression patterns of the 161 (40 + 109 + 12) genes de-regulated in the neocortex of TDP-43 cKO mice. The expression levels of up-regulated and down-regulated genes are highlighted with different red and blue colors, respectively, in the 2 columns, with the individual gene names indicated on the side of the columns. <bold>b</bold>, Cortical RNAs of TDP-43 cKO and Ctrl mice at the age of 3 months or 12 months were analyzed by Cufflink/MISO as described. The percentages (%) of the processing alternations, i.e. alternative uses of poly-A sites (“poly (A) extension”), extensions of conserved exons (“Exon extension”), inclusions of conserved exons (“Exon inclusion”), exclusion of conserved exons (“Exon exclusion”) and inclusion of cryptic exons (“Cryptic exon inclusion”), are shown</p></caption><graphic id="MO5" xlink:href="40478_2019_674_Fig5_HTML"></graphic></fig></p>
<p id="Par17">Significantly, most of the transcripts with increased abundance in TDP-43 cKO mice associated with activation of astrocytes, whereas the majority of transcripts with decreased abundance were associated with calcium signaling and synaptic transmission—likely reflecting the astrocytosis and synaptic transmision deficit that progressively occurred with aging in TDP-43 cKO cortex <bold>(</bold>Table <xref ref-type="table" rid="Tab1">1</xref><bold>)</bold>. Consistent with the correlation of these up/down regulated cortex genes with the age-dependent pathogenesis of TDP-43 cKO mice, most of the gene expression differences between the TDP-43 cKO cortex and Ctrl cotex became greater magnified as the mice aged (Fig. <xref ref-type="fig" rid="Fig5">5a</xref>-(i) and 5a-(iv)).<table-wrap id="Tab1"><label>Table 1</label><caption><p>The genes with altered mRNA levels in the neocortex of 3-month and 12-month-old TDP-43 cKO mice in comparison to the Ctrls are listed</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Gene symbol</th><th rowspan="3">Name</th><th rowspan="3">RefSeq ID</th><th colspan="2">Log2(TDP-43 cKO/ Ctrl)</th><th colspan="2">Significant (q&lt;0.05)</th><th rowspan="3">FTLD patient</th><th colspan="4">White et al. [<xref ref-type="bibr" rid="CR86">86</xref>]</th><th rowspan="3">Other references</th></tr><tr><th rowspan="2">3 Months</th><th rowspan="2">12 months</th><th rowspan="2">3 Months</th><th rowspan="2">12 months</th><th colspan="2">5 Months frontal cortex</th><th colspan="2">20 Months frontal cortex</th></tr><tr><th>Common</th><th>MB-</th><th>Common</th><th>MB-</th></tr></thead><tbody><tr><td>Rabggtb</td><td>Rab geranylgeranyltransferase beta subunit</td><td>NM_011231</td><td>6.21</td><td>-0.14</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Clec7a</td><td>C-type lectin domain containing 7A</td><td>NM_020008</td><td>4.06</td><td>2.09</td><td>●</td><td></td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Itgad</td><td>Integrin alpha-D</td><td>NM_001029872</td><td>2.99</td><td>1.45</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Brd3</td><td>bromodomain containing 3</td><td>NM_023336</td><td>2.88</td><td>0.11</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Atf3</td><td>activating transcription factor 3</td><td>NM_007498</td><td>2.47</td><td>1.90</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Slc6a3</td><td>solute carrier family 6 member 3</td><td>NM_010020</td><td>2.19</td><td>0.80</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Ccl9</td><td>chemokine (C-C motif) ligand 6</td><td>NM_011338</td><td>2.15</td><td>0.15</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Ccl6</td><td>chemokine (C-C motif) ligand 9</td><td>NM_009139</td><td>2.09</td><td>0.18</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cep112</td><td>centrosomal protein 112</td><td>NM_029586</td><td>1.76</td><td>0.04</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Pafah2</td><td>platelet-activating factor acetylhydrolase 2</td><td>NM_001285872</td><td>1.69</td><td>1.50</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Tlr2</td><td>toll like receptor 2</td><td>NP_036035</td><td>1.66</td><td>0.88</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Oasl2</td><td>2'-5' oligoadenylate synthetase-like 2</td><td>NM_011854</td><td>1.61</td><td>0.85</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Lag3</td><td>lymphocyte-activation gene 3</td><td>NM_008479</td><td>1.55</td><td>0.17</td><td>●</td><td></td><td></td><td>
●
</td><td></td><td></td><td></td><td></td></tr><tr><td>C3ar1</td><td>complement C3a receptor 1</td><td>NP_033909</td><td>1.52</td><td>0.18</td><td>●</td><td></td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Lyz1,Lyz2</td><td>lysozyme 1</td><td>NM_017372</td><td>1.48</td><td>0.86</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Ddhd1</td><td>DDHD domain containing 1</td><td>NM_176845</td><td>1.44</td><td>0.13</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Myo1f</td><td>myosin IF</td><td>NM_053214</td><td>1.39</td><td>0.60</td><td>●</td><td></td><td></td><td></td><td></td><td>
●
</td><td></td><td></td></tr><tr><td>Trem2</td><td>triggering receptor expressed on myeloid cells 2</td><td>NM_001272078</td><td>1.16</td><td>0.25</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Ptpn6</td><td>protein tyrosine phosphatase, non-receptor type 6</td><td>NM_001077705</td><td>1.15</td><td>0.63</td><td>●</td><td></td><td></td><td></td><td></td><td>
●
</td><td></td><td></td></tr><tr><td>Ifit3b</td><td>interferon-induced protein with tetratricopeptide repeats 3B</td><td>NM_001005858</td><td>1.11</td><td>0.31</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>C1qa</td><td>complement component 1, q subcomponent, alpha polypeptide</td><td>NM_007572</td><td>1.02</td><td>0.42</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Tyrobp</td><td>TYRO protein tyrosine kinase binding protein</td><td>NM_011662</td><td>1.01</td><td>0.19</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Lgals3bp</td><td>lectin, galactoside-binding, soluble, 3 binding protein</td><td>NM_011150</td><td>0.99</td><td>0.38</td><td>●</td><td></td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>C1qb</td><td>complement component 1, q subcomponent, beta polypeptide</td><td>NM_009777</td><td>0.96</td><td>0.41</td><td>●</td><td></td><td></td><td></td><td></td><td>
●
</td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>C1qc</td><td>complement component 1, q subcomponent, C chain</td><td>NM_007574</td><td>0.90</td><td>0.39</td><td>●</td><td></td><td></td><td></td><td></td><td>
●
</td><td></td><td></td></tr><tr><td>Fcrls</td><td>Fc receptor-like S, scavenger receptor</td><td>NM_030707</td><td>0.91</td><td>-0.11</td><td>●</td><td></td><td></td><td>
●
</td><td></td><td></td><td></td><td></td></tr><tr><td>Fcgr3</td><td>Fc receptor, IgG, low affinity III</td><td>NM_010188</td><td>0.83</td><td>0.53</td><td>●</td><td></td><td></td><td></td><td></td><td>
●
</td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Ctss</td><td>cathepsin S</td><td>NM_001267695</td><td>0.79</td><td>0.28</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Ripor1</td><td>Rho family interacting cell polarization regulator 1</td><td>NM_001081241</td><td>-1.48</td><td>-0.28</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Plod3</td><td>procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3</td><td>NM_011962</td><td>-1.23</td><td>0.14</td><td>●</td><td></td><td></td><td></td><td></td><td>
●
</td><td></td><td></td></tr><tr><td>Hist1h4m</td><td>histone cluster 1, H4m</td><td>NM_175654</td><td>-1.18</td><td>-0.30</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Zfp101</td><td>zinc finger protein 101</td><td>NM_009542</td><td>-1.02</td><td>-0.26</td><td>●</td><td></td><td></td><td></td><td></td><td>
●
</td><td></td><td></td></tr><tr><td>Dlg3</td><td>discs large MAGUK scaffold protein 3</td><td>NM_007863</td><td>-0.87</td><td>0.00</td><td>●</td><td></td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td>(LaClair et al. [<xref ref-type="bibr" rid="CR43">43</xref>])</td></tr><tr><td>Otof</td><td>otoferlin</td><td>NM_001100395</td><td>-0.86</td><td>-0.34</td><td>●</td><td></td><td></td><td></td><td>● (up)</td><td></td><td></td><td></td></tr><tr><td>Dock4</td><td>dedicator of cytokinesis 4</td><td>NM_172803</td><td>-0.79</td><td>-0.52</td><td>●</td><td></td><td></td><td></td><td></td><td>
●
</td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Abr</td><td>active BCR-related gene</td><td>NM_001291186</td><td>-0.79</td><td>-0.41</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td>(LaClair et al. [<xref ref-type="bibr" rid="CR43">43</xref>])</td></tr><tr><td>Syt17</td><td>synaptotagmin XVII</td><td>NM_138649</td><td>-0.70</td><td>-0.48</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Unc13a</td><td>unc-13 homolog A (C. elegans)</td><td>NP_001025044</td><td>-0.77</td><td>-0.48</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Rab11fip5</td><td>RAB11 family interacting protein 5 (class I)</td><td>NM_001003955</td><td>-0.69</td><td>-0.58</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Fgf21</td><td>fibroblast growth factor 21</td><td>NM_020013</td><td>0.00</td><td>0.00</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Gfap</td><td>glial fibrillary acidic protein</td><td>NM_001131020</td><td>1.74</td><td>1.43</td><td>●</td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Serpina3n</td><td>serine (or cysteine) peptidase inhibitor, clade A, member 3N</td><td>NP_035588</td><td>1.27</td><td>1.34</td><td>●</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>C4a,C4b</td><td>complement component 4a/b</td><td>NM_011413</td><td>1.64</td><td>1.46</td><td>●</td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>A2m</td><td>alpha-2-macroglobulin</td><td>NM_175628</td><td>1.37</td><td>2.09</td><td>●</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Tecpr1</td><td>tectonin beta-propeller repeat containing 1</td><td>NP_081686</td><td>-1.06</td><td>-0.93</td><td>●</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td>(LaClair et al. [<xref ref-type="bibr" rid="CR43">43</xref>])</td></tr><tr><td>Tarsl2</td><td>threonyl-tRNA synthetase-like 2</td><td>NM_172310</td><td>-1.00</td><td>-0.90</td><td>●</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Pitpnm3</td><td>PITPNM family member 3</td><td>NM_001024927</td><td>-0.97</td><td>-0.96</td><td>●</td><td>●</td><td></td><td></td><td>● (up)</td><td></td><td>● (up)</td><td>(LaClair et al. [<xref ref-type="bibr" rid="CR43">43</xref>])</td></tr><tr><td>Epop</td><td>elongin BC and polycomb repressive complex 2 associated protein</td><td>NM_175332</td><td>-0.80</td><td>-0.90</td><td>●</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Arc</td><td>activity regulated cytoskeletal-associated protein</td><td>NM_001276684</td><td>-0.84</td><td>-0.80</td><td>●</td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Cry2</td><td>cryptochrome 2 (photolyase-like)</td><td>NM_009963</td><td>-0.78</td><td>-0.58</td><td>●</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Lamp5</td><td>lysosomal-associated membrane protein family, member 5</td><td>NM_029530</td><td>-0.71</td><td>-0.96</td><td>●</td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Fam171a2</td><td>family with sequence similarity 171, member A2</td><td>NM_199200</td><td>-0.70</td><td>-0.65</td><td>●</td><td>●</td><td></td><td>
●
</td><td></td><td></td><td></td><td></td></tr><tr><td>Oxt</td><td>oxytocin/neurophysin I prepropeptide</td><td>NM_011025</td><td>1.11</td><td>2.95</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Plin4</td><td>perilipin 4</td><td>NM_020568</td><td>0.61</td><td>1.85</td><td></td><td>●</td><td></td><td>
●
</td><td></td><td></td><td></td><td></td></tr><tr><td>Irs4</td><td>insulin receptor substrate 4</td><td>NP_034702</td><td>0.22</td><td>1.79</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Itih3</td><td>inter-alpha trypsin inhibitor, heavy chain 3</td><td>NM_008407</td><td>0.69</td><td>1.27</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Etnppl</td><td>ethanolamine phosphate phospholyase</td><td>NM_001163587</td><td>0.63</td><td>1.07</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>AW551984</td><td>expressed sequence AW551984</td><td>NM_001199556</td><td>0.08</td><td>1.04</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Agt</td><td>angiotensinogen (serpin peptidase inhibitor, clade A, member 8)</td><td>NM_007428</td><td>0.31</td><td>0.97</td><td></td><td>●</td><td></td><td></td><td></td><td>
●
</td><td></td><td></td></tr><tr><td>Chd1l</td><td>chromodomain helicase DNA binding protein 1-like</td><td>NM_026539</td><td>-0.16</td><td>0.96</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Uggt2</td><td>UDP-glucose glycoprotein glucosyltransferase 2</td><td>NM_001081252</td><td>0.26</td><td>0.87</td><td></td><td>●</td><td></td><td></td><td></td><td>
●
</td><td></td><td></td></tr><tr><td>Vip</td><td>vasoactive intestinal polypeptide</td><td>NM_001313969</td><td>0.57</td><td>0.79</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Sparc</td><td>secreted acidic cysteine rich glycoprotein</td><td>NM_001290817</td><td>0.48</td><td>0.77</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td>
●
</td><td></td><td></td><td>● (down)</td><td></td></tr><tr><td>Baiap3</td><td>BAI1-associated protein 3</td><td>NM_001163270</td><td>0.24</td><td>0.72</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Nnat</td><td>neuronatin</td><td>NM_001291128</td><td>0.37</td><td>0.70</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Fam107a</td><td>family with sequence similarity 107, member A</td><td>NM_183187</td><td>0.38</td><td>0.69</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Sdc4</td><td>syndecan 4</td><td>NM_011521</td><td>0.33</td><td>0.68</td><td></td><td>●</td><td></td><td>
●
</td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Ptgds</td><td>prostaglandin D2 synthase (brain)</td><td>NM_008963</td><td>0.27</td><td>0.65</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Scg2</td><td>secretogranin II</td><td>NM_001310680</td><td>0.21</td><td>0.58</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Apod</td><td>apolipoprotein D</td><td>NM_001301353</td><td>0.38</td><td>0.54</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Tnnc1</td><td>troponin C1, slow skeletal and cardiac type</td><td>NP_033419</td><td>-1.20</td><td>-2.38</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Gm10635</td><td>predicted gene 10635</td><td>NR_045336</td><td>-1.10</td><td>-2.42</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Mylk3</td><td>myosin light chain kinase 3</td><td>NM_175441</td><td>-1.04</td><td>-2.28</td><td></td><td>●</td><td></td><td></td><td></td><td>
●
</td><td></td><td></td></tr><tr><td>Mecom</td><td>MDS1 and EVI1 complex locus</td><td>NM_007963</td><td>0.05</td><td>-1.76</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Rspo1</td><td>R-spondin 1</td><td>NP_619624</td><td>-0.80</td><td>-1.46</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Myl4</td><td>myosin, light polypeptide 4</td><td>NM_010858</td><td>-0.29</td><td>-1.36</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Ddit4l</td><td>DNA-damage-inducible transcript 4-like</td><td>NM_030143</td><td>-0.65</td><td>-1.13</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Grm2</td><td>glutamate receptor, metabotropic 2</td><td>NM_001160353</td><td>-0.52</td><td>-1.12</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cpne9</td><td>copine family member IX</td><td>NM_170673</td><td>-0.70</td><td>-1.04</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Ryr1</td><td>ryanodine receptor 1</td><td>NP_033135</td><td>-0.58</td><td>-0.98</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td>● (up)</td><td></td></tr><tr><td>Rassf3</td><td>Ras association domain family member 3</td><td>NP_620406</td><td>-0.26</td><td>-0.91</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Egr1</td><td>early growth response 1</td><td>NM_007913</td><td>-0.42</td><td>-0.90</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td>● (down)</td><td></td></tr><tr><td>Kcnt2</td><td>potassium channel, subfamily T, member 2</td><td>NM_001081027</td><td>-0.54</td><td>-0.89</td><td></td><td>●</td><td></td><td></td><td></td><td>
●
</td><td></td><td></td></tr><tr><td>Rims3</td><td>regulating synaptic membrane exocytosis 3</td><td>NM_182929</td><td>-0.38</td><td>-0.84</td><td></td><td>●</td><td></td><td>
●
</td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Pisd-ps3</td><td>phosphatidylserine decarboxylase, pseudogene 3</td><td>NR_003518</td><td>0.10</td><td>-0.86</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Kcnab3</td><td>potassium voltage-gated channel, shaker-related subfamily, beta member 3</td><td>NM_010599</td><td>-0.11</td><td>-0.86</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Fos</td><td>FBJ osteosarcoma oncogene</td><td>NM_010234</td><td>-0.77</td><td>-0.84</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Scube1</td><td>signal peptide, CUB domain, EGF-like 1</td><td>NM_001271472</td><td>-0.43</td><td>-0.83</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td>● (up)</td><td></td></tr><tr><td>Kcnh5</td><td>potassium voltage-gated channel, subfamily H (eag-related), member 5</td><td>NM_172805</td><td>-0.45</td><td>-0.83</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Inf2</td><td>inverted formin, FH2 and WH2 domain containing</td><td>NM_198411</td><td>-0.35</td><td>-0.83</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Acvr1c</td><td>activin A receptor, type IC</td><td>NM_001111030</td><td>-0.13</td><td>-0.82</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Hipk4</td><td>homeodomain interacting protein kinase 4</td><td>NP_001028487</td><td>-0.51</td><td>-0.81</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Scrt1</td><td>scratch family zinc finger 1</td><td>NM_130893</td><td>-0.26</td><td>-0.77</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Hapln4</td><td>hyaluronan and proteoglycan link protein 4</td><td>NM_177900</td><td>-0.47</td><td>-0.75</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Kif5a</td><td>kinesin family member 5A</td><td>NM_001039000</td><td>-0.52</td><td>-0.76</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Arhgap10</td><td>Rho GTPase activating protein 10</td><td>NP_001074833</td><td>0.00</td><td>-0.75</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Camk2n1</td><td>calcium/calmodulin-dependent protein kinase II inhibitor 1</td><td>NM_025451</td><td>-0.40</td><td>-0.74</td><td></td><td>●</td><td></td><td>
●
</td><td></td><td></td><td>● (down)</td><td></td></tr><tr><td>Car10</td><td>carbonic anhydrase 10</td><td>NP_082572</td><td>-0.33</td><td>-0.73</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Camk4</td><td>calcium/calmodulin-dependent protein kinase IV</td><td>NM_009793</td><td>-0.24</td><td>-0.73</td><td></td><td>●</td><td></td><td></td><td></td><td>
●
</td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Rims1</td><td>regulating synaptic membrane exocytosis 1</td><td>NM_001012623</td><td>-0.42</td><td>-0.73</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Eipr1</td><td>EARP complex and GARP complex interacting protein 1</td><td>NM_201357</td><td>-0.68</td><td>-0.73</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Rgs4</td><td>regulator of G-protein signaling 4</td><td>NM_009062</td><td>-0.52</td><td>-0.73</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Rapgef4</td><td>Rap guanine nucleotide exchange factor (GEF) 4</td><td>NM_001204165</td><td>-0.23</td><td>-0.70</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td>● (down)</td><td></td></tr><tr><td>Dagla</td><td>diacylglycerol lipase, alpha</td><td>NM_198114</td><td>-0.43</td><td>-0.69</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Diras2</td><td>DIRAS family, GTP-binding RAS-like 2</td><td>NM_001024474</td><td>-0.52</td><td>-0.69</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Gp1bb</td><td>glycoprotein Ib, beta polypeptide</td><td>NM_001001999</td><td>-0.65</td><td>-0.68</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Ano3</td><td>anoctamin 3</td><td>NM_001128103</td><td>-0.33</td><td>-0.67</td><td></td><td>●</td><td></td><td></td><td></td><td>
●
</td><td></td><td></td></tr><tr><td>Grm3</td><td>glutamate receptor, metabotropic 3</td><td>NM_181850</td><td>-0.26</td><td>-0.67</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Nefm</td><td>neurofilament, medium polypeptide</td><td>NM_008691</td><td>-0.53</td><td>-0.66</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Gabra3</td><td>gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3</td><td>NM_008067</td><td>-0.57</td><td>-0.65</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Rph3a</td><td>rabphilin 3A</td><td>NM_001302344</td><td>-0.39</td><td>-0.65</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Tbr1</td><td>T-box brain gene 1</td><td>NM_009322</td><td>-0.51</td><td>-0.63</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Satb1</td><td>special AT-rich sequence binding protein 1</td><td>NM_001163630</td><td>-0.39</td><td>-0.64</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Sh3gl2</td><td>SH3-domain GRB2-like 2</td><td>NM_019535</td><td>-0.22</td><td>-0.63</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Ephb6</td><td>Eph receptor B6</td><td>NM_001146351</td><td>-0.37</td><td>-0.63</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Kcnh3</td><td>potassium voltage-gated channel, subfamily H (eag-related), member 3</td><td>NM_010601</td><td>-0.43</td><td>-0.62</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Nrgn</td><td>neurogranin</td><td>NM_022029</td><td>-0.35</td><td>-0.62</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cadm2</td><td>cell adhesion molecule 2</td><td>NM_001145977</td><td>-0.17</td><td>-0.61</td><td></td><td>●</td><td></td><td></td><td></td><td>
●
</td><td></td><td></td></tr><tr><td>Camkk2</td><td>calcium/calmodulin-dependent protein kinase kinase 2, beta</td><td>NM_001199676</td><td>-0.44</td><td>-0.61</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Rorb</td><td>RAR-related orphan receptor beta</td><td>NM_001043354</td><td>-0.34</td><td>-0.60</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Scn4b</td><td>sodium channel, type IV, beta</td><td>NP_001013408</td><td>0.05</td><td>-0.60</td><td></td><td>●</td><td></td><td>
●
</td><td></td><td></td><td></td><td></td></tr><tr><td>Camk2a</td><td>calcium/calmodulin-dependent protein kinase II alpha</td><td>NM_001286809</td><td>-0.50</td><td>-0.60</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Nrn1</td><td>neuritin 1</td><td>NM_153529</td><td>-0.24</td><td>-0.60</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cdk5r2</td><td>cyclin-dependent kinase 5, regulatory subunit 2 (p39)</td><td>NM_009872</td><td>-0.42</td><td>-0.60</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Rbfox3</td><td>RNA binding protein, fox-1 homolog (C. elegans) 3</td><td>NM_001024931</td><td>-0.34</td><td>-0.60</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Gca</td><td>grancalcin</td><td>NP_663498</td><td>0.08</td><td>-0.59</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Osbpl1a</td><td>oxysterol binding protein-like 1A</td><td>NM_001252489</td><td>-0.39</td><td>-0.59</td><td></td><td>●</td><td></td><td></td><td></td><td>
●
</td><td></td><td></td></tr><tr><td>Vsnl1</td><td>visinin-like 1</td><td>NM_012038</td><td>-0.32</td><td>-0.59</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td>
●
</td><td></td><td></td></tr><tr><td>Adcy1</td><td>adenylate cyclase 1</td><td>NM_009622</td><td>-0.25</td><td>-0.59</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Neurod6</td><td>neurogenic differentiation 6</td><td>NM_009717</td><td>-0.41</td><td>-0.59</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>AI593442</td><td>expressed sequence AI593442</td><td>NM_001286641</td><td>-0.19</td><td>-0.58</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Stx1a</td><td>syntaxin 1A (brain)</td><td>NM_016801</td><td>-0.28</td><td>-0.57</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Nat8l</td><td>N-acetyltransferase 8-like</td><td>NP_001001985</td><td>-0.34</td><td>-0.57</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>3110035E14Rik</td><td>RIKEN cDNA 3110035E14 gene</td><td>NM_178399</td><td>-0.28</td><td>-0.57</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Zbtb18</td><td>zinc finger and BTB domain containing 18</td><td>NM_001012330</td><td>-0.22</td><td>-0.57</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Hlf</td><td>hepatic leukemia factor</td><td>NM_172563</td><td>-0.39</td><td>-0.56</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Lynx1</td><td>Ly6/neurotoxin 1</td><td>NM_011838</td><td>-0.28</td><td>-0.56</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Cadps2</td><td>Ca2+-dependent activator protein for secretion 2</td><td>NM_001252105</td><td>-0.53</td><td>-0.56</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Psd</td><td>pleckstrin and Sec7 domain containing</td><td>NM_133694</td><td>-0.47</td><td>-0.56</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Dhcr24</td><td>24-dehydrocholesterol reductase</td><td>NM_053272</td><td>-0.49</td><td>-0.54</td><td></td><td>●</td><td></td><td>
●
</td><td></td><td></td><td></td><td></td></tr><tr><td>2900011O08Rik</td><td>RIKEN cDNA 2900011O08 gene</td><td>NM_144518</td><td>-0.53</td><td>-0.53</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Dlgap3</td><td>discs, large (Drosophila) homolog-associated protein 3</td><td>NM_001302081</td><td>-0.43</td><td>-0.52</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Bhlhe40</td><td>basic helix-loop-helix family, member e40</td><td>NM_011498</td><td>-0.35</td><td>-0.53</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Pcp4</td><td>Purkinje cell protein 4</td><td>NM_008791</td><td>-0.04</td><td>-0.52</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td>
●
</td><td></td><td></td><td></td><td></td></tr><tr><td>Cntnap1</td><td>contactin associated protein-like 1</td><td>NM_016782</td><td>-0.38</td><td>-0.52</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cep170b</td><td>centrosomal protein 170B</td><td>NM_001024602</td><td>-0.42</td><td>-0.51</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Plcxd2</td><td>phosphatidylinositol-specific phospholipase C, X domain containing 2</td><td>NM_001134480</td><td>-0.16</td><td>-0.50</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cplx2</td><td>complexin 2</td><td>NM_009946</td><td>-0.26</td><td>-0.50</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Phyhip</td><td>phytanoyl-CoA hydroxylase interacting protein</td><td>NM_145981</td><td>-0.38</td><td>-0.50</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Snap25</td><td>synaptosomal-associated protein 25</td><td>NM_001291056</td><td>-0.43</td><td>-0.50</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Slc8a2</td><td>solute carrier family 8 (sodium/calcium exchanger), member 2</td><td>NM_001347561</td><td>-0.42</td><td>-0.50</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>D430041D05Rik</td><td>RIKEN cDNA D430041D05 gene</td><td>NM_001033347</td><td>-0.47</td><td>-0.49</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Tubb4a</td><td>tubulin, beta 4A class IVA</td><td>NM_009451</td><td>-0.38</td><td>-0.49</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Ppp3r1</td><td>protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I)</td><td>NM_024459</td><td>-0.25</td><td>-0.48</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td>
●
</td><td></td><td></td></tr><tr><td>Epdr1</td><td>ependymin related protein 1 (zebrafish)</td><td>NM_134065</td><td>-0.35</td><td>-0.48</td><td></td><td>●</td><td></td><td>
●
</td><td></td><td>
●
</td><td></td><td></td></tr><tr><td>Scn1b</td><td>sodium channel, voltage-gated, type I, beta</td><td>NM_011322</td><td>-0.20</td><td>-0.47</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Jph3</td><td>junctophilin 3</td><td>NM_020605</td><td>-0.39</td><td>-0.47</td><td></td><td>●</td><td></td><td>
●
</td><td></td><td></td><td></td><td></td></tr><tr><td>Syt13</td><td>synaptotagmin XIII</td><td>NM_030725</td><td>-0.33</td><td>-0.45</td><td></td><td>●</td><td></td><td>
●
</td><td></td><td></td><td></td><td>(Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>])</td></tr><tr><td>Snap91</td><td>synaptosomal-associated protein 91</td><td>NM_001277982</td><td>-0.53</td><td>-0.45</td><td></td><td>●</td><td>(Chen-Plotkin et al. [<xref ref-type="bibr" rid="CR17">17</xref>])</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Zfp365</td><td>zinc finger protein 365</td><td>NM_178679</td><td>-0.24</td><td>-0.44</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Atp1a1</td><td>ATPase, Na+/K+ transporting, alpha 1 polypeptide</td><td>NM_144900</td><td>-0.33</td><td>-0.44</td><td></td><td>●</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table><table-wrap-foot><p>The down-regulated genes are indicated by the "-" sign in the columns of Log2 (TDP-43 cKO/Ctrl). The genes that have been reported to have altered mRNA levels in the FTLD patients and in the striatum or hippocampus upon TDP-43 depletion are indicated in the far right column</p></table-wrap-foot></table-wrap></p>
<sec id="Sec11">
<title>Up/down-regulated TDP-43 cKO mouse neocortex genes associated with inflammation, autophagy, and synaptic function</title>
<p id="Par18">Significantly, 26 genes and 10 genes were up-regulated by &gt; 2 fold in 3- and 12-month-old TDP-43 cKO mouse neocortex, respectively (Fig. <xref ref-type="fig" rid="Fig5">5a</xref>-(ii) and Table <xref ref-type="table" rid="Tab1">1</xref>)<bold>,</bold> and most of them encoded the inflammatory proteins. Three out of these up-regulated genes, i.e. <italic>Gfap</italic>, <italic>Serpina3a</italic>, and <italic>C4a/C4b</italic>, were constitutively up-regulated at both the ages of 3 months and 12 months (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S5a), as also quantified by qRT-PCR (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S5b). Of the three genes, increase of <italic>Gfap</italic> and <italic>Serpina3n</italic> mRNAs in reactive astrocyte was reported in brain injury and in several neurodegeneration diseases [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR93">93</xref>]. We also calculated and compared the intron sizes of TDP-43-regulated genes in the Ctrl and TDP-43 cKO mouse neocortex. It was found that the total lengths of the introns of down-regulated neocortex genes in TDP-43 cKO mice (the median values being 30,061 bp and 28,604 bp at the ages of 3 months and 12 months, respectively) were larger than those of control (the median value being 11,754 bp), whereas the trend was not observed for the up-regulated neocotex genes (the median values being 9968 bp and 13,098 bp at the ages of 3 months and 12 months, respectively) (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S5c). To assess the empirical <italic>P</italic> values, we calculated the median values of the total intron lengths of 100 genes randomly selected from the annotated mouse protein-coding genes and the process was repeated for 10,000 times. Indeed, the down-regulated neocortex genes of the TDP-43 cKO mice at either the age of 3 months or 12 months possessed significantly longer total introns than expected, with the P values &lt; 0.001. This result is consistent with the previous observation that down-regulated genes in striatum upon TDP-43 reduction tend to have long introns [<xref ref-type="bibr" rid="CR58">58</xref>].</p>
<p id="Par19">Increase of Gfap protein in the cortex and hippocampus of TDP-43 cKO mice at the ages of 3 months and 12 months was confirmed by Western blotting, respectively (Fig. <xref ref-type="fig" rid="Fig1">1b</xref>). Note that one additional band in GFAP immunoblotting in protein extracts of 3-month-old mice could be the isoform of GFAP protein. On the other hand, most of 20 down-regulated genes in the neocortex of 3-month-old TDP-43 cKO mice <bold>(</bold>Fig. <xref ref-type="fig" rid="Fig5">5a</xref><bold>)</bold> encoded proteins involved in the functions of synapse, e.g. <italic>Dlg3</italic>, endosome, e.g. <italic>Lamp5</italic>, and autophagosome, e.g. <italic>Tecpr1</italic>
<bold>(</bold>Table <xref ref-type="table" rid="Tab1">1</xref><bold>)</bold>. Furthermore, eight of these 20 down-regulated genes were constitutively repressed in the neocortex of TDP-43 cKO mice at the age of 12 month <bold>(</bold>Fig. <xref ref-type="fig" rid="Fig5">5a</xref> and Table <xref ref-type="table" rid="Tab1">1</xref><bold>)</bold>.</p>
<p id="Par20">We also analyzed the altered expression of several genes by Western blotting. Firstly, autophagy defect was reported in <italic>Tecprl</italic> gene knockout mice with increased expression of an autophagy substrate, p62 [<xref ref-type="bibr" rid="CR14">14</xref>]. As shown in Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S5d, the level of p62 protein was increased in the cortex of TDP-43 cKO mice at all ages analyzed. Secondly, consistent with the RNA-seq data <bold>(</bold>Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Fig. S5a<bold>)</bold> and RT-qPCR analysis (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S5b), the levels of SAP102 protein, which was encoded by the <italic>Dlg3</italic> gene mentioned above and involved in synaptic plasticity by regulating the recycling of NMDA receptor NMDAR [<xref ref-type="bibr" rid="CR13">13</xref>], in the cortex and synaptosome of TDP-43 cKO mice were reduced in an age-dependent manner <bold>(</bold>Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S5e<bold>)</bold>. Since NMDA receptor (NMDAR)-mediated responses regulated the levels and activities of CaMKII family members [<xref ref-type="bibr" rid="CR48">48</xref>], we also examined the levels of different synaptic proteins including the CaM kinase proteins CaMK4, NMDAR submit NR2b, and phospho-Erk1/2. Indeed, the amounts of these proteins were all greatly reduced in the cortex and/or synaptosome of 12-month-old TDP-43 cKO mice in comparison to the Ctrl mice <bold>(</bold>Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S5e<bold>)</bold>, while the amount of SAP102 was decreased in the cortex and synaptosome of early stage TDP-43 cKO mice. Thus, depletion of TDP-43 in the cortex indeed would down-regulate the expression of a specific set of genes and this could contribute in part to the impairment of synaptic functions (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4) and behaviour deficits (Fig. <xref ref-type="fig" rid="Fig2">2</xref>) in an age-dependent manner.</p>
</sec>
<sec id="Sec12">
<title>Mis-regulation of RNA processing</title>
<p id="Par21">Abrrant RNA processing was increasingly recognized as a potential contributor to the development/ pathogenesis of neurological diseases [<xref ref-type="bibr" rid="CR68">68</xref>]. Among the different RNA processing events, alternative splicing (AS) is one major mechanism for the enhancement of transcriptome diversity. A growing number of human diseases were correlated with RNA mis-splicing [<xref ref-type="bibr" rid="CR3">3</xref>]. There are several different types of alternative splicing events including inclusion/exclusion of conserved (consitutively present in wild type RNAs) or non-conserved (cryptic)(absent in the wild type RNAs) exons as well as the alternative splicing site selection leading to extension of conserved exons. To investigate the regulatory role of AS in the forebrain neurons of TDP-43 cKO mice, we used the Cufflink [<xref ref-type="bibr" rid="CR77">77</xref>] and MISO (Mixture of Isoforms) [<xref ref-type="bibr" rid="CR40">40</xref>] programs to examine usage changes of alternatively spliced exons (ASEs) and poly(A) sites. In comparison to the Ctrl mice<bold>,</bold> 55 and 57 transcript processing events exhibited remarkably usage changes of ASEs or polyA sites in the neocortex of 3- and 12-month-old TDP-43 cKO mice, respectively, (Fig. <xref ref-type="fig" rid="Fig5">5b</xref>, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S6 and S7). Most (&gt; 85%) of these changed transcript events were ASEs <bold>(</bold>Fig. <xref ref-type="fig" rid="Fig5">5b</xref> and Table <xref ref-type="table" rid="Tab2">2</xref>). Inclusion of cryptic exons was also observed (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S6d and Table 2). Notably, some of these transcript events with siginificant usage changes were found only in 3-month-old TDP-43 cKO mice, e.g. <italic>Pdp1</italic>, or only in 12-month-old TDP-43 cKO mice, e.g. <italic>Ranbp17</italic>, while others were found at both ages <bold>(</bold>Table <xref ref-type="table" rid="Tab2">2</xref>). For example, polyA site usage of the <italic>Kctd2</italic> transcript was altered in cKO mice at both ages and the <italic>Polr1b</italic> transcript was altered only in 3-month-old TDP-43 cKO mice (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S7 and Table <xref ref-type="table" rid="Tab2">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Genes with altered mRNA processing patterns in the neocortex of TDP-43 cKO mice</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>Gene</th><th>Location</th><th>Strand</th><th colspan="2">Significant</th><th colspan="2">Δmisoψ</th><th colspan="2">White et al. [<xref ref-type="bibr" rid="CR86">86</xref>]</th><th>References</th></tr><tr><th></th><th></th><th></th><th></th><th>3 Months</th><th>12 Months</th><th>3 Months</th><th>12 Months</th><th>5 Months</th><th>20 Months</th><th></th></tr></thead><tbody><tr><td>Cryptic</td><td>Cdh22</td><td>Ch2:165183239-165183371</td><td>-</td><td>●</td><td>●</td><td>0.61</td><td>0.54</td><td></td><td></td><td>Jeong et al. [<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>Cryptic</td><td>Camk1g</td><td>Ch1:193368867-193368952</td><td>-</td><td>●</td><td>●</td><td>0.46</td><td>0.59</td><td></td><td></td><td>Jeong et al. [<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>Cryptic</td><td>Slc45a1</td><td>Ch4:150630400-150630454</td><td>-</td><td>●</td><td>●</td><td>0.32</td><td>0.13</td><td></td><td></td><td>Jeong et al. [<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>Cryptic</td><td>Synj2bp</td><td>Ch12:81509828-81510051</td><td>-</td><td>●</td><td>●</td><td>0.39</td><td>0.30</td><td></td><td></td><td>Jeong et al. [<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>Cryptic</td><td>Hgsnat</td><td>Ch8:25945949-25945996</td><td>-</td><td>●</td><td>●</td><td>0.22</td><td>0.19</td><td></td><td></td><td>Jeong et al. [<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>Cryptic</td><td>Adnp2</td><td>Ch18:80138153-80138304</td><td>-</td><td>●</td><td>●</td><td>0.45</td><td>0.49</td><td></td><td></td><td>Jeong et al. [<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>Cryptic</td><td>Abca8b</td><td>Ch11:109975240-109975477</td><td>-</td><td>●</td><td>●</td><td>0.18</td><td>0.18</td><td></td><td></td><td></td></tr><tr><td>Cryptic</td><td>Upf3a</td><td>Ch8:13789928-13789967</td><td>+</td><td>●</td><td></td><td>0.17</td><td>0.07</td><td></td><td></td><td></td></tr><tr><td>Cryptic</td><td>Letm1</td><td>Ch5:33779574-33779604</td><td>-</td><td>●</td><td></td><td>0.13</td><td>0.04</td><td></td><td></td><td>Jeong et al. [<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>Inclusion</td><td>Sort1</td><td>Ch3:108355472-108355570</td><td>+</td><td>●</td><td>●</td><td>0.35</td><td>0.40</td><td>●(exclusion)</td><td>●(exclusion)</td><td>Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>]</td></tr><tr><td>Inclusion</td><td>Islr2-02</td><td>Ch9:58200272-58200461</td><td>-</td><td>●</td><td>●</td><td>0.36</td><td>0.37</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Islr2-01</td><td>Ch9:58200272-58200443</td><td>-</td><td>●</td><td>●</td><td>0.30</td><td>0.29</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Bsg</td><td>Ch10:80136663-80136743</td><td>-</td><td>●</td><td>●</td><td>0.25</td><td>0.13</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Vps13d</td><td>Ch4:145099352-145099463</td><td>-</td><td>●</td><td>●</td><td>0.23</td><td>0.18</td><td></td><td>●(inclusion)</td><td></td></tr><tr><td>Inclusion</td><td>Smg5</td><td>Ch3:88340649-88340763</td><td>+</td><td>●</td><td>●</td><td>0.20</td><td>0.10</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Smarca4</td><td>Ch9:21677953-21678051</td><td>+</td><td>●</td><td>●</td><td>0.20</td><td>0.24</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Uggt2</td><td>Ch14:119043908-119044028</td><td>-</td><td>●</td><td>●</td><td>0.19</td><td>0.08</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Elac2</td><td>Ch11:65005454-65005505</td><td>-</td><td>●</td><td>●</td><td>0.15</td><td>0.12</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Kcnmb4</td><td>Ch10:116443772-116443912</td><td>-</td><td>●</td><td>●</td><td>0.11</td><td>0.08</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Dnajc5</td><td>Ch2:181548926-181549000</td><td>+</td><td>●</td><td>●</td><td>0.10</td><td>0.13</td><td></td><td></td><td>Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>]</td></tr><tr><td>Inclusion</td><td>Sun1</td><td>Ch5:139230773-139230838</td><td>+</td><td>●</td><td>●</td><td>-0.14</td><td>0.32</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Pdp1-01</td><td>Ch4:11965614-11965648</td><td>-</td><td>●</td><td></td><td>0.40</td><td>0.24</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Tmem2</td><td>Ch19:21780171-21780252</td><td>+</td><td>●</td><td></td><td>0.40</td><td>0.19</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Zfp30</td><td>Ch7:29788049-29788175</td><td>+</td><td>●</td><td></td><td>0.32</td><td>-0.04</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Zkscan16</td><td>Ch4:58943943-58944160</td><td>+</td><td>●</td><td></td><td>0.29</td><td>0.18</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Nfia-02</td><td>Ch4:98081725-98081816</td><td>+</td><td>●</td><td></td><td>0.12</td><td>0.02</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Lrrk2</td><td>Ch15:91785371-91785527</td><td>+</td><td>●</td><td></td><td>0.06</td><td>-0.01</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Atxn1</td><td>Ch13:45849519-45849588</td><td>-</td><td>●</td><td></td><td>0.10</td><td>0.09</td><td></td><td></td><td>Polymenidou et al. [<xref ref-type="bibr" rid="CR58">58</xref>]</td></tr><tr><td>Inclusion</td><td>Ranbp17</td><td>Ch11:33283908-33283990</td><td>-</td><td></td><td>●</td><td>-0.17</td><td>0.28</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Srr</td><td>Ch11:74919437-74919662</td><td>-</td><td></td><td>●</td><td>0.11</td><td>0.22</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Atad2b</td><td>Ch12:4970406-4970468</td><td>+</td><td></td><td>●</td><td>-0.03</td><td>0.15</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Kctd10</td><td>Ch5:114376771-114376866</td><td>-</td><td></td><td>●</td><td>0.05</td><td>0.06</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Pdp1-02</td><td>Ch4:11965614-11965648</td><td>-</td><td></td><td>●</td><td>#REF!</td><td>0.05</td><td></td><td></td><td></td></tr><tr><td>Inclusion</td><td>Mettl22</td><td>Ch16:8482127-8482167</td><td>+</td><td></td><td>●</td><td>0.00</td><td>0.03</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Cobl</td><td>Ch11:12306958-12307128</td><td>-</td><td>●</td><td>●</td><td>-0.34</td><td>-0.41</td><td>●(inclusion)</td><td></td><td></td></tr><tr><td>Exclusion</td><td>Scamp1</td><td>Ch13:94210577-94210678</td><td>-</td><td>●</td><td>●</td><td>-0.31</td><td>-0.26</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Ddx50</td><td>Ch10:62627521-62627682</td><td>-</td><td>●</td><td>●</td><td>-0.27</td><td>-0.37</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Kcnip2-02</td><td>Ch19:45797091-45797186</td><td>-</td><td>●</td><td>●</td><td>-0.23</td><td>-0.29</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Dtwd1</td><td>Ch2:126158410-126158553</td><td>+</td><td>●</td><td>●</td><td>-0.27</td><td>-0.19</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Nlgn3</td><td>ChX:101307075-101307134</td><td>+</td><td>●</td><td>●</td><td>-0.22</td><td>-0.15</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Lzts1</td><td>Ch8:69182213-69182331</td><td>-</td><td>●</td><td>●</td><td>-0.12</td><td>-0.15</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Nrxn1</td><td>Ch17:90701988-90702011</td><td>-</td><td>●</td><td>●</td><td>-0.09</td><td>-0.16</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Shisa4</td><td>Ch1:135373152-135373285</td><td>-</td><td>●</td><td>●</td><td>-0.07</td><td>-0.14</td><td></td><td>●(inclusion)</td><td></td></tr><tr><td>Exclusion</td><td>Rdh13</td><td>Ch7:4444978-4445122</td><td>-</td><td>●</td><td>●</td><td>0.08</td><td>-0.26</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Atp11b</td><td>Ch3:35843571-35843696</td><td>+</td><td>●</td><td></td><td>-0.44</td><td>-0.28</td><td></td><td>●(inclusion)</td><td></td></tr><tr><td>Exclusion</td><td>Gpatch1</td><td>Ch7:35281332-35281480</td><td>-</td><td>●</td><td></td><td>-0.36</td><td>0.00</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Kcnip2-01</td><td>Ch19:45796279-45796332</td><td>-</td><td>●</td><td></td><td>-0.21</td><td>-0.18</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Nfia-01</td><td>Ch4:98041551-98041679</td><td>+</td><td>●</td><td></td><td>-0.15</td><td>0.00</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Dzip3</td><td>Ch16:48951543-48952160</td><td>-</td><td>●</td><td></td><td>-0.13</td><td>0.01</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Cacna1b-01</td><td>Ch2:24618255-24618362</td><td>-</td><td>●</td><td></td><td>-0.04</td><td>0.01</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Tmcc2</td><td>Ch1:132380657-132381172</td><td>-</td><td>●</td><td></td><td>-0.05</td><td>0.01</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Pcm1-01</td><td>Ch8:41313302-41313460</td><td>+</td><td>●</td><td></td><td>-0.08</td><td>-0.01</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Cdk19-02</td><td>Ch10:40466638-40466769</td><td>+</td><td></td><td>●</td><td>-0.02</td><td>-0.04</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Max</td><td>Ch12:76939430-76939514</td><td>-</td><td></td><td>●</td><td>-0.08</td><td>-0.05</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Phactr2</td><td>Ch10:13253342-13253879</td><td>-</td><td></td><td>●</td><td>-0.16</td><td>-0.08</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Cdk19-01</td><td>Ch10:40454015-40454072</td><td>+</td><td></td><td>●</td><td>0.02</td><td>-0.05</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Rimbp2</td><td>Ch5:128846922-128846991</td><td>-</td><td></td><td>●</td><td>-0.01</td><td>-0.09</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Clasp1-01</td><td>Ch1:118512175-118512222</td><td>+</td><td></td><td>●</td><td>0.02</td><td>-0.12</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Clasp1-03</td><td>Ch1:118541675-118541698</td><td>+</td><td></td><td>●</td><td>0.07</td><td>-0.12</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Cntln-01</td><td>Ch4:84984369-84984500</td><td>+</td><td></td><td>●</td><td>-0.02</td><td>-0.20</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Agfg1</td><td>Ch1:82891460-82891507</td><td>+</td><td></td><td>●</td><td>-0.16</td><td>-0.26</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Repin1</td><td>Ch6:48594862-48594976</td><td>+</td><td></td><td>●</td><td>-0.07</td><td>-0.24</td><td></td><td></td><td></td></tr><tr><td>Exclusion</td><td>Ppp3ca</td><td>Ch3:136932011-136932040</td><td>+</td><td></td><td>●</td><td>-0.09</td><td>-0.11</td><td>●(inclusion)</td><td>●(inclusion)</td><td></td></tr><tr><td>Exclusion</td><td>Hspa13</td><td>Ch16:75758632-75758727</td><td>-</td><td></td><td>●</td><td>0.01</td><td>-0.08</td><td></td><td></td><td></td></tr><tr><td>Extension</td><td>Wbscr22</td><td>Ch5:135063781-135063921</td><td>-</td><td>●</td><td>●</td><td>0.17</td><td>0.19</td><td></td><td></td><td>Jeong et al. [<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>Extension</td><td>Chga</td><td>Ch12:102558298-102558559</td><td>+</td><td>●</td><td>●</td><td>0.08</td><td>0.06</td><td></td><td></td><td>Jeong et al. [<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>Extension</td><td>Bptf</td><td>Ch11:107054456-107055318</td><td>-</td><td>●</td><td>●</td><td>-0.10</td><td>-0.11</td><td></td><td></td><td></td></tr><tr><td>PolyA extension</td><td>Rapgefl1</td><td>Ch11:98851076-98857648</td><td>-</td><td>●</td><td>●</td><td>0.17</td><td>0.21</td><td></td><td></td><td>Jeong et al. [<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>PolyA extension</td><td>Kctd2</td><td>Ch11:115430313-115433591</td><td>+</td><td>●</td><td>●</td><td>0.14</td><td>0.11</td><td></td><td></td><td></td></tr><tr><td>PolyA extension</td><td>Kcnj4</td><td>Ch15:79505196-79505875</td><td>-</td><td>●</td><td>●</td><td>0.09</td><td>0.06</td><td></td><td></td><td></td></tr><tr><td>PolyA extension</td><td>Ergic1</td><td>Ch17:26655067-26658770</td><td>+</td><td>●</td><td>●</td><td>0.05</td><td>0.09</td><td></td><td></td><td></td></tr><tr><td>PolyA extension</td><td>Syt17</td><td>Ch7:118378587-118379874</td><td>-</td><td>●</td><td>●</td><td>0.06</td><td>0.16</td><td></td><td></td><td></td></tr><tr><td>PolyA extension</td><td>Polr1b</td><td>Ch2: 129125214:129126791</td><td>+</td><td>●</td><td></td><td>0.14</td><td>0.13</td><td></td><td></td><td></td></tr><tr><td>PolyA extension</td><td>Elk1</td><td>ChX:20932683-20935548</td><td>-</td><td></td><td>●</td><td>0.19</td><td>0.22</td><td></td><td></td><td></td></tr><tr><td>PolyA extension</td><td>Ppp3cc</td><td>Ch14:70214901-70215786</td><td>-</td><td></td><td>●</td><td>0.08</td><td>0.09</td><td></td><td></td><td></td></tr></tbody></table><table-wrap-foot><p>The ψ (PSI, percentage of spliced in) score was defined as the percentage of transcripts containing the alternative splicing events and/ or alternative poly(A) site usage. The mRNAs with increase of splcing events, i.e. conserved exon inclusion/ exclusion, cryptic exon inclusion, and exon extension, as well as change of poly(A) site usage are indicated by Δ ψ &gt; 0, mRNA with decrease of the processing events are indicated by Δ ψ &lt; 0. Unpaired t test was used to calculate the significance from data of 3 independent samples. Note that changes of the pre-mRNA processing events of several genes including <italic>Cob1</italic> in the TDP-43 cKO mice are oppisite to those observed in the TDP-43(Q331K) knock-in mice (White et al. [<xref ref-type="bibr" rid="CR86">86</xref>])</p></table-wrap-foot></table-wrap></p>
<p id="Par22">We then examined some of the differential RNA processing events by RT-qPCR and/or semi-quantitative RT-PCR (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S8 and Figure S9). For instance, Sortilin 1 (<italic>Sort1</italic>), a member of a family of cellular vacuolar protein sorting 10 (VSP10)-domain receptors, was primarily expressed in neurons and a key player in regulating the neuronal viability and function [<xref ref-type="bibr" rid="CR87">87</xref>]. It was proposed that TDP-43 regulates the splicing of <italic>Sort1</italic> mRNA in mouse striatum and cell lines [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. We confirmed <italic>Sort1</italic>(wt) as the main mRNA isoform encoding sortilin in mouse cortex by RT-PCR and Western blotting (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S9a and b). However, depletion of TDP-43 expression in the neocortex of TDP-43 cKO mice led to the accumulation at all stages of the higher molecular weight RNA isoform <italic>Sort1</italic>(e17b) encoding a non-functional progranulin receptor Sortilin 1(e17b) [<xref ref-type="bibr" rid="CR60">60</xref>] (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S8a, S9a and b). Quantification analysis of <italic>Sort1</italic> mRNA levels by qRT-PCR in different mouse brain areas confirmed this observation in both 3- and 12-month-old TDP-43 cKO mice (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S8a). Other events of conserved and cryptic exon inclusions induced by depletion of TDP-43 were also comfirmed by qRT-PCR, as exemplified for <italic>Dnajc5</italic>,<italic>CaMK1g,</italic>and <italic>Adnp2</italic>, respectively (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S8). Notably, the expression levels of the wild type isoforms of <italic>Sort 1</italic> and <italic>Dnajc5</italic> in the cortex of TDP-43 cKO mice were unaltered (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S9c), while those of <italic>CaMK1g</italic> and <italic>Adnp2</italic> were unchanged in the cortex of 3-month-old TDP-43 cKO mice (upper panels, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S9d) but moderately increased at the age of 12 months (lower panels, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S9d).</p>
</sec>
<sec id="Sec13">
<title>Mis-regulation of circular RNA processing in TDP-43 cKO mice</title>
<p id="Par23">Circular RNAs (circRNAs) are RNA molecules in which a covalent linkage termed a “backsplice” has formed between a downstream 3′ splice site and an upstream 5′ splice site in a linear pre-messenger RNA [<xref ref-type="bibr" rid="CR73">73</xref>]. Previous studies have lead to the identification of thousands of circRNAs in diverse species [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR84">84</xref>] that are enriched in neuronal tissues and may play specific roles in neuronal processes [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR92">92</xref>]. Analysis of our RNA-seq data by the NCLscan pipeline [<xref ref-type="bibr" rid="CR19">19</xref>] revealed that the expression levels of 182 circRNAs in the neocortex were significantly different between the TDP-43 cKO and Ctrl mice (Fig. <xref ref-type="fig" rid="Fig6">6</xref> and Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Table S1). Among them, the expression levels of 22 circRNAs were significantly altered in the neocortex of 3- as well as 12-month-old TDP-43 cKO mice when compared to the Ctrl mice. The levels of 39 circRNAs were changed only at the age of 3 months and 121 circRNAs were altered only at the age of 12 months (Fig. <xref ref-type="fig" rid="Fig6">6a</xref> and Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Table S1). Notably, a considerable percentage of the circRNAs and their corresponding co-linear mRNA isoforms exhibited different changes of their expression levels in TDK-43 cKO in comparison to the Ctrl mice (Fig. <xref ref-type="fig" rid="Fig6">6b</xref>). This result reflects the previous observation that circRNAs and their co-linear counterparts could compete with each other for biogenesis during splicing [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. The biological significance of the alterations of expression levels of the circRNAs in the TDP-43 cKO mouse neocortex await to be examined.<fig id="Fig6"><label>Fig. 6</label><caption><p>RNA-Seq analysis of circRNAs. <bold>a</bold> Upper panel, list of the numbers of cirRNAs in the neocortex of 3 each of TDP-43 cKO and Ctrl mice at the ages of 3 months and 12 months, respectively. Lower plot, venn diagram showing the numbers of cortex circRNAs the expression levels of which were different between the TDP-43 cKO and Ctrl mice at the ages of 3 months and 12 months, respectively. Note that the levels of 22 cricRNAs were changed at both ages. <bold>b</bold> Upper panels, scatter plot showing the correlation of log<sub>2</sub> fold change (FC, TDP-43 cKO/Ctrl) of cortex circRNAs (x axis) and their cognate linear mRNAs (y axis) the levels of which were altered in TDP-43 cKO mice only at the age of 3 months or only at the age of 12 months in comparison to Ctrls. Lower panels, scatter plot showing the correlation of log<sub>2</sub> FC of neocortex circRNAs (x axis) and their cognate linear RNAs (y axis) the levels of which were changed at both the ages of 3 months and 12 months in TDP-43 cKO mice in comparison to Ctrls. Blue circles indicate changes of the expression levels of only the circRNAs, while green squares indicate changes of the expression levels of both the circRNAs and their cognate mRNAs counterparts</p></caption><graphic id="MO8" xlink:href="40478_2019_674_Fig6_HTML"></graphic></fig></p>
</sec>
</sec>
</sec>
<sec id="Sec14">
<title>Discussion</title>
<p id="Par24">TDP-43 proteinopathy is assocaited with more than 95% of ALS (ALS-TDP) and more than 50% of FTLD (FTLD-TDP) [<xref ref-type="bibr" rid="CR47">47</xref>]. A gain-of-toxicity mechanism for early pathogenesis of FTLD-TDP or ALS-TDP has been suggested in view of the aberrant RNA metabolism and/or purturbed autoregulation of TDP-43 caused by mutant TDP-43 in different mouse models [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR89">89</xref>]. One the other hand, a common characteristic of TDP-43 pathology at the later stage of FTLD-TDP or ALS-TDP is the loss of nuclear TDP-43 with concomitant cytoplasmic TDP-43 accumulation in neurons and glia [<xref ref-type="bibr" rid="CR54">54</xref>]. This nuclear clearing provides a disease mechanism that is at least partially driven by the loss of normal TDP-43 function in the nucleus, as supported by studies of different mouse models with knockout or knockdown of TDP-43 expression [<xref ref-type="bibr" rid="CR89">89</xref>, <xref ref-type="bibr" rid="CR91">91</xref>]. The presence of the cytoplasmic TDP-43(+) inclusions would also cause gain of one or more cytotoxic properties [<xref ref-type="bibr" rid="CR44">44</xref>].</p>
<p id="Par25">As summerized in Fig. <xref ref-type="fig" rid="Fig7">7</xref>, this study shows that CaMKII-directed conditional depletion of TDP-43 expression in the forebrain neurons has adverse effects on the mice, leading to shorter life span and a range of age-dependent phenotypes on the behavioural, cellular, as well as molecular levels that mimic FTLD, especially bvFTLD [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR75">75</xref>]. Specifically, depletion of TDP-43 in <italic>αCaMKII</italic>-expressing neurons in the mouse forebrain (Fig. <xref ref-type="fig" rid="Fig1">1</xref>) results in progressive perturbation of social behaviour (Fig. <xref ref-type="fig" rid="Fig2">2a</xref>), development of dementia-like behaviour (Fig. <xref ref-type="fig" rid="Fig2">2b</xref>), and impairment of learning/memory (Fig. <xref ref-type="fig" rid="Fig2">2c</xref>). The behaviour deficits are accompanied with brain atrophy and neurodegeneration in the cortical hippocampal region and massive astrocytosis (Fig. <xref ref-type="fig" rid="Fig3">3</xref>-<xref ref-type="fig" rid="Fig4">4</xref>). These findings together with analysis of the transcriptomes/gene expression profiles of mouse neocortex at the pre-symptomatic and post-symptomatic strages (Fig. <xref ref-type="fig" rid="Fig5">5</xref>, Fig. <xref ref-type="fig" rid="Fig6">6</xref> and Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figures S5-S10) demonstrate the function of TDP-43 in cognition, and synaptic function in the adult brain. Notably, the large neurons in cortical layer V of TDP-43 cKO mice are more voulunerable to TDP-43 depletion (Fig. <xref ref-type="fig" rid="Fig4">4</xref>). This data is consisitent with the finding by Yang et al. [<xref ref-type="bibr" rid="CR91">91</xref>], in which 10% reduction of TDP-43 protein level in the forebrain region of a TDP-43 knockdown mouse model could causes ~ 25% loss of large neurons in cortical layer V. Thus, there appears to be a selective vulnerability of the forebrain neurons, with distinct neuronal populations in different cortical layers compromised by the depletion of TDP-43. Notably, depletion of TDP-43 did not affect the sensory neurons of above mouse model [<xref ref-type="bibr" rid="CR91">91</xref>]. Overall, this study demonstrates that loss-of-function of TDP-43 in the forebrain neurons would lead to a range of pathological changes of the mice on the phenotypic, molecular, and cellular levels that mimic those in FTLD-TDP.<fig id="Fig7"><label>Fig. 7</label><caption><p>Age-dependence of FTLD-like pathogenesis of TDP-43 cKO mice. The ages (months) of the detection of different behaviour (blue), cellular, and molecular pathologies in TDP-43 cKO mice upon conditional depletion of TDP-43 in their forebrain neurons are indicated along the time line on the top. Also listed in the 2 lower boxes are mis-regulated genes associated with specific pathogenic event, e.g. <italic>Gfap</italic>/ <italic>Serpina3a</italic>/ <italic>C4a</italic>/ <italic>C4b</italic>/ <italic>A2m</italic> and astrocyte activation, etc., are identified by RNA-Seq analysis of the TDP-43 cKO mouse neocortex on 3 and 12 months (genes altered in FTLD patients are indicated by red color), respectively. For more details, see text</p></caption><graphic id="MO9" xlink:href="40478_2019_674_Fig7_HTML"></graphic></fig></p>
<p id="Par26">Since one-fifth of the genes the expression of which are altered in TDP-43 cKO mice are also affected in FTLD patients [<xref ref-type="bibr" rid="CR17">17</xref>] (Table <xref ref-type="table" rid="Tab1">1</xref>), mis-regulation of TDP-43 RNA targets through the loss of TDP-43 function could at least in part contribute to the impairment of synaptic functions and disease pathogenesis of FTLD-TDP.</p>
<p id="Par27">Comparison of our RNA-seq data (Table <xref ref-type="table" rid="Tab1">1</xref>) to the Mouse Genome Informatics database (MGI) [<xref ref-type="bibr" rid="CR8">8</xref>] has revealed that the mRNA levels of genes associated with anxiety-related behaviour and/ or social behaviours are significantly altered in the neocortex of TDP-43 cKO mice (Additional file <xref ref-type="media" rid="MOESM3">3</xref>: Table S2)<bold>.</bold> Notably, <italic>Slc6a3</italic>, a gene encoding a sodium-dependent dopamine transporter and associated with anxiety disorder in autism spectrum disorder [<xref ref-type="bibr" rid="CR56">56</xref>], is upregulated (by 4 fold) in the neocortex of TDP-43 cKO mice but only at the age of 3 months (Additional file <xref ref-type="media" rid="MOESM3">3</xref>: Table S2) [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR90">90</xref>]. On the other hand, 16 of the rest 17 anxiety- and/or social behaviour–related genes listed in Additional file <xref ref-type="media" rid="MOESM3">3</xref>: Table S2 are up- or down-regulated in the neocortex TDP-43 cKO mice mainly at the age of 12 months when the behaviour abnormality shows up (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). Egr1 was also demostrated in a TDP-43<sup>Q331K</sup> knockin mice at the age of 20 months (Table <xref ref-type="table" rid="Tab1">1</xref>) [<xref ref-type="bibr" rid="CR86">86</xref>].</p>
<p id="Par28">Similarly, the cognition deficencies of the TDP-43 cKO mice are also associated with altered expression levels of specific genes, particularly those involved in synaptic transmission, as revealed by the transcriptome anaysis (Table <xref ref-type="table" rid="Tab1">1</xref> and Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S10) and electro-physiology measurement (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4). Besides those illustrated in Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S5, the expression level of <italic>dlg3</italic>, which encodes a major excitatory postsynaptic density protein SAP102 important in NMDARs recycling [<xref ref-type="bibr" rid="CR95">95</xref>], is significantly down-regulated in 3-month-old TDP-43 cKO mice as compared with Ctrl mice (Table <xref ref-type="table" rid="Tab1">1</xref>). In addition, several other synaptic function-associated genes, e.g. <italic>dlgap3, snap25,</italic> are down-regulated in the cortex of 12-month-old TDP-43 cKO mice (Table <xref ref-type="table" rid="Tab1">1</xref>). Among the proteins encoded by these genes, Dlgap3 (PSD95-associated protein 3) is an excitatory postsynaptic protein implicated in the pathogenesis of obsessive-compulsive behaviours [<xref ref-type="bibr" rid="CR85">85</xref>], and Snap-25 is a component of the SNARE protein complex and a promising cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease [<xref ref-type="bibr" rid="CR10">10</xref>]. With respect to the abnormal LTP and LTD (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4), the protein levels of CaMKII and p-Erk (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S5c and d) are decreased in the cortex of TDP-43 cKO mice. Altogether, it appears that combined deficiencies of the expression of a set of forebrain genes contributed to the age-dependent cognition impairment of TDP-43 cKO mice. However, down-regulation of synaptic genes could also be the results from the degeneration of the according brain region with neuron loss in TDP-43 cKO mice.</p>
<p id="Par29">Patients with dementia (e.g., FTLD) often exhibit activation of inflammatory reponse [<xref ref-type="bibr" rid="CR27">27</xref>]. In TDP-43 cKO mice, the progressive increase of astrocytosis in SLM region of hippocampus and RS region of the cortex (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3) is associated with upregulation of a range of inflammatory genes, including <italic>Gfap</italic>, <italic>C4a/C4b</italic>, <italic>Serpina3n</italic>, and <italic>A2m,</italic> at both 3- and 12 months of age (Fig. <xref ref-type="fig" rid="Fig7">7</xref> and Table <xref ref-type="table" rid="Tab1">1</xref>). Particularly, <italic>Serpina3n</italic>, is a marker of persistent reactive gliosis response induced in inflammation [<xref ref-type="bibr" rid="CR93">93</xref>] and in ALS [<xref ref-type="bibr" rid="CR25">25</xref>]. Several other genes induced in microglia activation, e.g., <italic>Cst7</italic> and <italic>Clec7a</italic>, are also upregulated in TDP-43 cKO mice (Fig. <xref ref-type="fig" rid="Fig5">5d</xref> and Table <xref ref-type="table" rid="Tab1">1</xref>). Taken together, the transcriptome analysis indicates that chronic neuroinflammation in TDP-43 cKO mice and by implication in FTLD-TDP patients’ results in part from mis-regulation of these genes.</p>
<p id="Par30">Depletion of TDP-43 in the mouse forebrain also results in aberrant splicing of ~ 50 RNA transcripts in the cortex of 3- and/ or 12-month-old TDP-43 cKO mice (Fig. <xref ref-type="fig" rid="Fig5">5</xref> and Table <xref ref-type="table" rid="Tab2">2</xref>). Importantly, among these transcripts, <italic>Sort1</italic>, <italic>Adnp2</italic>, and <italic>Cdh22</italic>, the mutations or functional variants of which are associated with aging or neurodegenerative disorders [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. Furthermore, aberrant splcing of several genes including <italic>Dnajc5, Sort1, Pdp1</italic>, and <italic>Kcnip2,</italic> which also occus in TDP-43 knockdown cells of the striatum [<xref ref-type="bibr" rid="CR58">58</xref>], does not affect the levels of their wild type mRNA isoforms (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S9c). Consistently, the amounts of <italic>Dnajc5</italic> protein in the cortex of TDP-43 cKO and Ctrl mice are similar (data not shown). On the other hand, the truncated sortilin protein accumulates in the cortex of TDP-43 cKO mice at different ages (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S9b). Interestingly, decreasing the <italic>Sort1</italic> e17b inclusion was reported by TDP-43<sup>Q331K</sup> knock-in mice with a mild FTD phenotype [<xref ref-type="bibr" rid="CR86">86</xref>](Table <xref ref-type="table" rid="Tab1">1</xref>). Since sortilin is a major neuronal APOE receptor [<xref ref-type="bibr" rid="CR12">12</xref>], the truncated <italic>Sort1</italic> (e17b) could act as a decoy receptor [<xref ref-type="bibr" rid="CR60">60</xref>] competing with the wild type sortilin in the cortex of TDP-43 cKO mice thus affecting the neuronal viability and causing neurodegenertion.</p>
<p id="Par31">Finally, cryptic exons are present in transcripts from a set of genes, including <italic>Camk1g</italic>, <italic>Hgsnat</italic>, <italic>Synj2bp</italic>, <italic>Adnp2</italic>, and <italic>Abca8b,</italic> in the neocortex of 3- and/or 12-month-old TDP-43 cKO mice (Table <xref ref-type="table" rid="Tab2">2</xref>). Intriguingly, inclusion of the cryptic exon in <italic>CaMK1g</italic> would result in the loss-of-function of CaMK1γ that has been implicated in aging and ALS [<xref ref-type="bibr" rid="CR22">22</xref>]. Besides <italic>CaMK1g</italic> and other gene transcripts reported previously [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR46">46</xref>], we identified some novel cryptic exon inclusion events in several transcripts upon TDP-43 depletion (Table <xref ref-type="table" rid="Tab2">2</xref>). Notably, cryptic exon inclusions often introduce premature termination codons (PTCs) and thereby result in nonsense-mediated decay (NMD) [<xref ref-type="bibr" rid="CR34">34</xref>] of the inserted RNA transcripts. It has also been reported that TDP-43 could autoregulate itself through NMD [<xref ref-type="bibr" rid="CR58">58</xref>]. Thus, we speculate that the accumulation of a portion of the cryptic exon-containing transcripts in the cortex of TDP-43 cKO mice might result from loss of TDP-43 function in NMD of these transcripts.</p>
</sec>
<sec id="Sec15">
<title>Conclusions</title>
<p id="Par32">In summary, we have generated a conditional mouse model (TDP-43 cKO) with depletion of TDP-43 in the neurons of cortex and hippocampus. The TDP-43 cKO mice exhibit a spectrum of age-dependent social behaviour change, dementia-like behaviour, impairment of the cognition functions, and decline of ADL. The development of neurodegenerative pathology in TDP-43 cKO mice is closely associated with their behaviour and cognition changes, both of which are well correlated with the age-dependent alterations of the cortex transcriptomes. Notably, the transcriptomopathies of the TDP-43 cKO mouse cortex consist of changes of mRNA levels as well as pre-mRNA splicing patterns of many genes. Related to the latter changes, alternative splicing is known to play an essential role in brain function and mutations in factors involved in splicing regulation cause a range of neurological diseases [<xref ref-type="bibr" rid="CR68">68</xref>]. Transcriptome analyse of autopsied brains from patients with ALS/FTLD reported have identified thousands of alternative splicing changes in part regulated by hnRNP [<xref ref-type="bibr" rid="CR59">59</xref>] including TDP-43.</p>
<p id="Par33">Overall, this study not only supports that loss-of-function of TDP-43 could be a major cause for FTLD-TDP pathogenesis, but also suggests a list of potential TDP-43 target genes that may be useful for future therapeutic development of FTLD-TDP.</p>
</sec>
<sec id="Sec16">
<title>Materials and methods</title>
<sec id="Sec17">
<title>Generation of TDP-43 conditional knockout mouse</title>
<p id="Par34">The <italic>Tardbp</italic> allele was knocked out specifically in the postmitotic pyramidal neurons in the forebrain by crossing mice carrying the <italic>Tardbp</italic> conditional allele (<italic>Tardbp</italic><sup>lx</sup>) with mice carrying a Cre-recombinase transgene driven by the <italic>CaMKIIα</italic>-promoter. The viability and weight of the mice were monitored regularly. Genotyping of the mice was performed by PCR of genomic DNAs from the tail biopsies.</p>
</sec>
<sec id="Sec18">
<title>RNA-seq analysis</title>
<p id="Par35">For RNA-seq, the rRNA-depleted cortical RNAs from three biological replicates of sex-matched TDP-43 cKO as well as littermate Ctrl mice were converted to cDNAs and sequenced them in a strand-specific manner at National Center of Genomic Medicine (NCGM).. The RNAs were extracted from intact mouse cortical tissues and their concentrations determined using NanoDrop 8000 (Thermo Scientific). The RNA integrity was determined by Fragment Analyzer (Advanced Analytical Technologies). cDNAs from 5 μg of total RNA was used as an input material for library preparation using TruSeq RNA Sample Preparation Kit v2 (Illumina). Insert sizes of the libraries were confirmed using Fragment Analyzer (Advanced Analytical Technologies). The libraries were multiplexed and then sequenced on Illumina HiSeq2000 (Illumina) to generate 50 M of pair end 100 base pair reads per library. Data were processed using the TopHat, Cufflinks [<xref ref-type="bibr" rid="CR77">77</xref>] and MISO [<xref ref-type="bibr" rid="CR40">40</xref>].</p>
</sec>
<sec id="Sec19">
<title>RNA-seq normalization</title>
<p id="Par36">The number of mapped fragments per kilobase of exon, per million mapped reads (FPKM) for each annotated protein-coding gene was determined to establish a metric of normalized gene expression. Approximately 80~85% of annotated protein-coding genes in mouse satisfied at least 1 FPKM in either condition. To judge the significance of differences between TDP-43 cKO and Ctrl mice, false discovery rates (q &lt; 0.05) were used as the criteria for different replicates. The q value is an adjusted <italic>P</italic> value taking in to account the false discovery rate (FDR). We calculated the q value because the expression levels of thousands of genes from a small sample set (3 individual mice) were measured. The expression levels of transcripts in the neocortex of TDP-43 cKO mice relative to Ctrl mice were represented by log2 transformed values.</p>
</sec>
<sec id="Sec20">
<title>Analysis of alternative splicng</title>
<p id="Par37">The ψ (PSI, percentage of spliced in) score was defined as the percentage of transcripts containing the alternative splicing events and/ or alternative poly(A) site usage. The mRNAs with increase of splcing events, i.e. conserved exon inclusion/ exclusion, cryptic exon inclusion, and exon extension, as well as change of poly(A) site usage are indicated by Δ ψ &gt; 0. mRNAs with decrease of the processing events are indicated by Δ ψ &lt; 0. Multiple t test was used to calculate the significance from data of 3 independent samples and the Holm-Sidak method was used to correct for multiple t test.</p>
</sec>
<sec id="Sec21">
<title>Clustering analysis of protein-coding and noncoding transcripts</title>
<p id="Par38">For the clustering, transcripts with an estimated expression of a minimum of 0.2 FPKM in both TDP-43 cKO and Ctrl mice were selected for analysis. The list of protein-coding transcripts was compiled based on the RefSeq/Enterz/Vega definitions.</p>
</sec>
<sec id="Sec22">
<title>Identification and analysis of circRNAs</title>
<p id="Par39">circRNAs were identified by NCLscan (version 1.6; <ext-link ext-link-type="uri" xlink:href="https://github.com/TreesLab/NCLscan">https://github.com/TreesLab/NCLscan</ext-link>/TreesLab/NCLscan) [<xref ref-type="bibr" rid="CR20">20</xref>], which was reported to outperform other publicly-available tools in terms of precision and to be robust to background noise [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR94">94</xref>], on the basis of the mouse reference genome (GRCm38) and the GENCODE annotation (version M10). The differential expression analysis was performed by DEseq2 [<xref ref-type="bibr" rid="CR2">2</xref>] and edgeR [<xref ref-type="bibr" rid="CR64">64</xref>], in which the circRNA supporting reads were normalized by Relative Log Expression (RLE) and Trimmed Mean of M-values (TMM), respectively. The <italic>P</italic> values were evaluated by the Wald test (DEseq2) and the Fisher’s exact test (edgeR), and then adjusted by the Benjamini-Hochberg procedure. In this study, the significantly differential expression of circRNAs between different stages should satisfy DEseq adjusted <italic>P</italic> &lt; 0.05 and edgeR adjusted P &lt; 0.05 simultaneously.</p>
</sec>
<sec id="Sec23">
<title>Quantitative reverse transcription PCR (qRT-PCR)</title>
<p id="Par40">Total RNAs were extracted from the cortex, hippocampus, and cerebellum of 3-and 12-month-old TDP-43 cKO mice and their Ctrl littermates (<italic>N</italic> = 6 for each genotype) using TRIzol reagents (Thermo Fisher Scientific). Synthesis of cDNA followed the manufacturer’s protocol (Invitrogen). qRT-PCR was performed using Roche qPCR FastMix (Roche). Primers were designed using a primer design software (LightCycler Probe Design Software 2.0 from Roche). The expression levels were normalized to <italic>gapdh</italic>, and data are represented as fold change relative to the Ctrl mRNA levels. Significant differences were determined using un-paired <italic>t</italic> tests.</p>
</sec>
<sec id="Sec24">
<title>Nesting behaviour</title>
<p id="Par41">Single-housed mice were transferred into a new cage with nest-building material, a 5 × 5 cm square of white compressed cotton pads (Nestlets TM; Ancare, Bellmore, NY) in a random corner. After 6, 24, and 48 h, nest building was scored on a scale of 0–5, as previously described [<xref ref-type="bibr" rid="CR21">21</xref>]. All data are shown means ± SEM and analyzed using un-paired <italic>t</italic> tests.</p>
</sec>
<sec id="Sec25">
<title>Social interaction test</title>
<p id="Par42">This test has been successfully employed to study social affiliation and interest in social novelty or social discrimination (social memory). The test was performed as described previously [<xref ref-type="bibr" rid="CR70">70</xref>]. Briefly, in the first 10-min session, a test mouse was placed in the center of the three-chamber unit, where two empty wire cages were located in the left and right chambers to habituate the test mouse. The mouse was allowed to freely explore each chamber. In the second 10-min session, an age- and gender-matched C57BL/6J mouse (S1) that had never been exposed to the test mouse, was placed in one of the two wire cages. The wire cage on the other side remained empty (E). Then, the test mouse was placed in the center, and allowed to freely explore the chamber for 10 min. The test mouse was removed and in the last 10-min session, a second age- and gender-matched C57BL/6J stranger mouse (S2) that had never been exposed to the test mouse, was placed in one wire cage, which previously served as an empty cage. Thus, the test mouse would now have the choice between a mouse that was already familiar (S1) and a new stranger mouse (S2). The test mouse was placed in the center, and allowed to freely explore the chamber for 10 min. The movement of the mouse was recorded by a camera. The recorded video file was further analyzed by off-line video tracking software (EthoVision XT 7.0). Time spent in each chamber, and time spent within a 5 cm radius proximal to each wire cage were measured. All data shown are means ± SEM and analyzed using two-way ANOVA with Bonferroni’s post hoc analysis.</p>
</sec>
<sec id="Sec26">
<title>Light/ dark box test</title>
<p id="Par43">The light–dark box was custom made (45 × 20 × 20 cm) and divided into two parts: 1/3 was painted black, covered by the lid, and separated from the white compartment by the wall containing an opening (13 × 5 cm) at the floor level. The light side was illuminated by two 40 W light bulbs 50 cm above the floor. Each mouse was released in the center of the light compartment (facing away from the opening) and allowed to explore the area for 10 min. Video tracking equipment and software (EthoVision XT 8, Noldus) were used for following the animal’s position and movement. In addition, rearings and attempts (stretched attend postures at the opening) to enter either the light or the dark compartment were recorded manually.</p>
</sec>
<sec id="Sec27">
<title>Rotarod rod test</title>
<p id="Par44">Mice were trained at the age of 2 months and then subjected to rotarod test monthly. The latencies before falling from the rod was recorded for 3 consecutive days.</p>
</sec>
<sec id="Sec28">
<title>Immunohistochemistry and histochemmistry staining</title>
<p id="Par45">Mice were anesthetized and perfused with 4% paraformaldehyde. The hemispheres were embedded in paraffin, sliced into 10-μm sections, and mounted on slices. For immunostaining, the sections were washed with 0.1 M PBS buffer, quenched by 1% H<sub>2</sub>O<sub>2</sub>, blocked in serum with 0.05% Triton X-100 for 30 min, and incubated in rabbit anti-TDP-43 (Genetex, 1:1000), mouse anti-glial fibrillary acidic protein (GFAP) (1:1000), mouse anti-SMI-32 (1:1000) and mouse anti-NeuN (Milipore, 1:200) at 4 °C overnight. After rinsing in PBS, the sections were incubated with biotinnlated goat antibody (Vector) for 60 min, followed by incubation with the avidin–biotin complex (Vector) for 45 min. The reaction products were developed by 3,3′-diaminobenzidine (Sigma, St Louis, MO).</p>
<p id="Par46">To identify the cellular localization of TDP-43, slices were combined with hematoxylin. The hematoxylin and eosin (H&amp;E) stain was used to visualize the overall morphology of the mouse brain. Nissl staining was applied to characterize the hippocampus size, cortical layer thickness, and neuron number. All data are presented as the mean with standard error, and statistical significance was tested by paired t-test.</p>
</sec>
<sec id="Sec29">
<title>Electrophysiology</title>
<p id="Par47">Standard protocol was followed as described previously, with some modifications. In short, the mice were decapitated and their brains rapidly removed and placed in ice-cold artificial CSF (ACSF). 450 μm thick sections of isolated mouse hippocampus were transferred into an interface-type holding chamber in oxygenated ACSF (95% O<sub>2</sub> and 5% CO<sub>2</sub>) at room temperature to allow recovery for at least 90 min before the recording. The field excitatory postsynaptic potential (fEPSP) at Schaffer collateral branches in CA1 region of the hippocampal slices was recorded. Three trains of stimuli at 100 Hz separated by 60 s were applied for LTP induction, and low frequency stimulation (1 Hz for 15 min) were applied for LTD induction. The slopes of the fEPSP were measured and the synaptic responses were normalized to the average of the baseline. All data are presented as the mean with mean standard deviation. Statistical significance was tested by paired t-test.</p>
</sec>
<sec id="Sec30">
<title>Statistical analyses</title>
<p id="Par48">GraphPad Prism software was used for most statistical analysis. The statistical significance between means of control and TDP-43 cKO mouse groups was calculated by the two-tailed Student’s t-test. For comparisons involving more than two groups, one-way or two way ANOVA were used. Data are presented as measures for group means, and <italic>P</italic> &lt; 0.05 was considered significant. Numbers of animals per group used in each experiment are indicated in figure legends.</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Additional files</title>
<sec id="Sec31">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="40478_2019_674_MOESM1_ESM.pdf"><label>Additional file 1:</label><caption><p><bold>Figure S1.</bold> Altered activity of daily living (ADL) of TDP-43 cKO mice. <bold>Figure S2.</bold> Immunohistochemistry staining of brain slices. <bold>Figure S3.</bold> Persisting reactive astrocytosis in TDP-43 cKO mouse forebrain. <bold>Figure S4.</bold> Electrophysiology measurements. <bold>Figure S5.</bold> Mis-regulated genes in TDP-43 cKO mice. <bold>Figure S6.</bold> Alternations of the processing events of cortical RNAs in TDP-43 cKO mice. <bold>Figure S7.</bold> The alternative uses of poly(A) sites in the cortical RNAs of TDP-43 cKO mice. <bold>Figure S8.</bold> qRT-PCR validation of RNA splicing events altered in 3- and 12-month-old TDP-43 cKO mice. <bold>Figure S9.</bold> Validation of altered splicing events in TDP-43 cKO mice. <bold>Figure S10.</bold> Calcium signaling and synaptic long term potentiation pathway analysis using Ingenuity Pathway Analysis (IPA). (PDF 2990 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="40478_2019_674_MOESM2_ESM.pdf"><label>Additional file 2:</label><caption><p>
<bold>Table S1.</bold> List of the chromosome numbers, donor positions, acceptors positions and gene names of the transcripts from which the individual circularRNAs change in the neocortex of 3- and 12-month-old TDP-43 cKO mice, but not Ctrl mice are listed. (PDF 141 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="40478_2019_674_MOESM3_ESM.pdf"><label>Additional file 3:</label><caption><p>
<bold>Table S2.</bold> Changes of the mRNA levels of social behaviour-related genes in the neocortex of TDP-43 cKO mice relative to Ctrl mice. (PDF 72 kb)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We thank Drs. Yuh-Shan Jou and Wen-Chang Lin (IBMS, Academia Sinica) for their generous gifts of experimental advices. We thank the National Center for Genome Medicine for the technical/bioinformatics/statistics support and the expertise of Hsing Tsung Wu in bioinformatic analysis is greatly appreciated. The expertise of Sue-Ping Lee and Shu-Mei Huang in the Microscopy Core at IMB and all members of Bioinformatics Core at IMB are greatly appreciated. We sincerely convey our gratitude to IMB and Academia Sinica. This work was supported by the Frontier of Science Award from the National Science Council and a Senior Investigator Award from the Academia Sinica, Taipei, Taiwan (R.O.C.).</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>L.S.W and W.C.C. designed, performed, and interpreted this study with contributions from M.C.W. performed the experiments in Fig. <xref ref-type="fig" rid="Fig3">3c, and d</xref>, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figures S2, S4, and S5. L.S.W and Y.C.W. analyzed sequencing experiments in Fig. <xref ref-type="fig" rid="Fig4">4</xref>, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figures S7, and S8. C.Y.C, Y.H.T and T.J.C. analyzed sequencing experiments in Fig. <xref ref-type="fig" rid="Fig5">5</xref>. L.S.W and C.K.S. wrote the paper, and all authors edited it. C.K.S. obtained funding for this study. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar1">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar2">
<title>Publisher’s Note</title>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alami</surname>
<given-names>NH</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Carrasco</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Winborn</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>SSW</given-names>
</name>
<name>
<surname>Kiskinis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Winborn</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Freibaum</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Kanagaraj</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations</article-title>
<source/>Neuron
          <year>2014</year>
<volume>81</volume>
<fpage>536</fpage>
<lpage>543</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2013.12.018</pub-id>
<pub-id pub-id-type="pmid">24507191</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anders</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Differential expression analysis for sequence count data</article-title>
<source/>Genome Biol
          <year>2010</year>
<volume>11</volume>
<fpage>R106</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2010-11-10-r106</pub-id>
<pub-id pub-id-type="pmid">20979621</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anthony</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gallo</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Aberrant RNA processing events in neurological disorders</article-title>
<source/>Brain Res
          <year>2010</year>
<volume>1338</volume>
<fpage>67</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2010.03.008</pub-id>
<pub-id pub-id-type="pmid">20226177</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Akiyama</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nonaka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tsuchiya</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hashizume</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis</article-title>
<source/>Biochem Biophys Res Commun
          <year>2006</year>
<volume>351</volume>
<fpage>602</fpage>
<lpage>611</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2006.10.093</pub-id>
<pub-id pub-id-type="pmid">17084815</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnold</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Huelga</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Lagier-Tourenne</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Polymenidou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ditsworth</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kordasiewicz</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>McAlonis-Downes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Platoshyn</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Parone</surname>
<given-names>PA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2013</year>
<volume>110</volume>
<fpage>E736</fpage>
<lpage>E745</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1222809110</pub-id>
<pub-id pub-id-type="pmid">23382207</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashwal-Fluss</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pamudurti</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Ivanov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bartok</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Hanan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Evantal</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Memczak</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rajewsky</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kadener</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>circRNA biogenesis competes with pre-mRNA splicing</article-title>
<source/>Mol Cell
          <year>2014</year>
<volume>56</volume>
<fpage>55</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2014.08.019</pub-id>
<pub-id pub-id-type="pmid">25242144</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bianco</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Takanaga</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Crescenzi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kos</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Zhuang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Gouveia</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene</article-title>
<source/>J Bone Miner Res
          <year>2007</year>
<volume>22</volume>
<fpage>274</fpage>
<lpage>285</lpage>
<pub-id pub-id-type="doi">10.1359/jbmr.061110</pub-id>
<pub-id pub-id-type="pmid">17129178</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blake</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Eppig</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Kadin</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Bult</surname>
<given-names>CJ</given-names>
</name>
<collab>the Mouse Genome Database G</collab>
</person-group>
<article-title>Mouse genome database (MGD)-2017: community knowledge resource for the laboratory mouse</article-title>
<source/>Nucleic Acids Res
          <year>2017</year>
<volume>45</volume>
<fpage>D723</fpage>
<lpage>D729</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkw1040</pub-id>
<pub-id pub-id-type="pmid">27899570</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blundell</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kaeser</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Sudhof</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>RIM1alpha and interacting proteins involved in presynaptic plasticity mediate prepulse inhibition and additional behaviors linked to schizophrenia</article-title>
<source/>J Neurosci
          <year>2010</year>
<volume>30</volume>
<fpage>5326</fpage>
<lpage>5333</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0328-10.2010</pub-id>
<pub-id pub-id-type="pmid">20392954</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brinkmalm</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brinkmalm</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Honer</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Frolich</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hausner</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Minthon</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hansson</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Wallin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zetterberg</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Blennow</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease</article-title>
<source/>Mol Neurodegener
          <year>2014</year>
<volume>9</volume>
<fpage>53</fpage>
<pub-id pub-id-type="doi">10.1186/1750-1326-9-53</pub-id>
<pub-id pub-id-type="pmid">25418885</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burrell</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Kiernan</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Vucic</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hodges</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Motor neuron dysfunction in frontotemporal dementia</article-title>
<source/>Brain
          <year>2011</year>
<volume>134</volume>
<fpage>2582</fpage>
<lpage>2594</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awr195</pub-id>
<pub-id pub-id-type="pmid">21840887</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carlo</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Gustafsen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mastrobuoni</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Burgert</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hartl</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rohe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nykjaer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Herz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Heeren</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The pro-neurotrophin receptor sortilin is a major neuronal apolipoprotein E receptor for catabolism of amyloid-beta peptide in the brain</article-title>
<source/>J Neurosci
          <year>2013</year>
<volume>33</volume>
<fpage>358</fpage>
<lpage>370</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2425-12.2013</pub-id>
<pub-id pub-id-type="pmid">23283348</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Sanz-Clemente</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Nicoll</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Roche</surname>
<given-names>KW</given-names>
</name>
</person-group>
<article-title>SAP102 mediates synaptic clearance of NMDA receptors</article-title>
<source/>Cell Rep
          <year>2012</year>
<volume>2</volume>
<fpage>1120</fpage>
<lpage>1128</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2012.09.024</pub-id>
<pub-id pub-id-type="pmid">23103165</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>A mammalian autophagosome maturation mechanism mediated by TECPR1 and the Atg12-Atg5 conjugate</article-title>
<source/>Mol Cell
          <year>2012</year>
<volume>45</volume>
<fpage>629</fpage>
<lpage>641</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2011.12.036</pub-id>
<pub-id pub-id-type="pmid">22342342</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>TJ</given-names>
</name>
</person-group>
<article-title>Biogenesis, identification, and function of exonic circular RNAs</article-title>
<source/>Wiley Interdiscip Rev RNA
          <year>2015</year>
<volume>6</volume>
<fpage>563</fpage>
<lpage>579</lpage>
<pub-id pub-id-type="doi">10.1002/wrna.1294</pub-id>
<pub-id pub-id-type="pmid">26230526</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Regulation of circRNA biogenesis</article-title>
<source/>RNA Biol
          <year>2015</year>
<volume>12</volume>
<fpage>381</fpage>
<lpage>388</lpage>
<pub-id pub-id-type="doi">10.1080/15476286.2015.1020271</pub-id>
<pub-id pub-id-type="pmid">25746834</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen-Plotkin</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Geser</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Plotkin</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Kwong</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Grossman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Van Deerlin</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Trojanowski</surname>
<given-names>JQ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>VM</given-names>
</name>
</person-group>
<article-title>Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration</article-title>
<source/>Hum Mol Genet
          <year>2008</year>
<volume>17</volume>
<fpage>1349</fpage>
<lpage>1362</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddn023</pub-id>
<pub-id pub-id-type="pmid">18223198</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen-Plotkin</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Trojanowski</surname>
<given-names>JQ</given-names>
</name>
</person-group>
<article-title>TAR DNA-binding protein 43 in neurodegenerative disease</article-title>
<source/>Nat Rev Neurol
          <year>2010</year>
<volume>6</volume>
<fpage>211</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="doi">10.1038/nrneurol.2010.18</pub-id>
<pub-id pub-id-type="pmid">20234357</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chuang</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>LY</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>MY</given-names>
</name>
</person-group>
<article-title>NCLscan: accurate identification of non-co-linear transcripts (fusion, trans-splicing and circular RNA) with a good balance between sensitivity and precision</article-title>
<source/>Nucleic Acids Res
          <year>2016</year>
<volume>44</volume>
<fpage>e29</fpage>
<pub-id pub-id-type="doi">10.1093/nar/gkv1013</pub-id>
<pub-id pub-id-type="pmid">26442529</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crawley</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Goodwin</surname>
<given-names>FK</given-names>
</name>
</person-group>
<article-title>Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines</article-title>
<source/>Pharmacol Biochem Behav
          <year>1980</year>
<volume>13</volume>
<fpage>167</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="doi">10.1016/0091-3057(80)90067-2</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deacon</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Assessing nest building in mice</article-title>
<source/>Nat Protoc
          <year>2006</year>
<volume>1</volume>
<fpage>1117</fpage>
<lpage>1119</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2006.170</pub-id>
<pub-id pub-id-type="pmid">17406392</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide association analyses in Han Chinese identify two new susceptibility loci for amyotrophic lateral sclerosis</article-title>
<source/>Nat Genet
          <year>2013</year>
<volume>45</volume>
<fpage>697</fpage>
<lpage>700</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2627</pub-id>
<pub-id pub-id-type="pmid">23624525</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferguson</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Aldag</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Insel</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<article-title>Oxytocin in the medial amygdala is essential for social recognition in the mouse</article-title>
<source/>J Neurosci
          <year>2001</year>
<volume>21</volume>
<fpage>8278</fpage>
<lpage>8285</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-20-08278.2001</pub-id>
<pub-id pub-id-type="pmid">11588199</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<mixed-citation publication-type="other">Fratta P, Sivakumar P, Humphrey J, Lo K, Ricketts T, Oliveira H, Brito-Armas JM, Kalmar B, Ule A, Yu Y et al (2018) Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis. EMBO J 37. 10.15252/embj.201798684</mixed-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukada</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yasui</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kitayama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Doi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nakano</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Gene expression analysis of the murine model of amyotrophic lateral sclerosis: studies of the Leu126delTT mutation in SOD1</article-title>
<source/>Brain Res
          <year>2007</year>
<volume>1160</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2007.05.044</pub-id>
<pub-id pub-id-type="pmid">17583678</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghidoni</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Paterlini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Albertini</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Binetti</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Benussi</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Losing protein in the brain: the case of progranulin</article-title>
<source/>Brain Res
          <year>2012</year>
<volume>1476</volume>
<fpage>172</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2012.01.075</pub-id>
<pub-id pub-id-type="pmid">22348647</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glass</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Saijo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Winner</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Marchetto</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Gage</surname>
<given-names>FH</given-names>
</name>
</person-group>
<article-title>Mechanisms underlying inflammation in neurodegeneration</article-title>
<source/>Cell
          <year>2010</year>
<volume>140</volume>
<fpage>918</fpage>
<lpage>934</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2010.02.016</pub-id>
<pub-id pub-id-type="pmid">20303880</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glynn</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Harte</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Reim</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>GP</given-names>
</name>
<name>
<surname>Morton</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Clorgyline-mediated reversal of neurological deficits in a Complexin 2 knockout mouse</article-title>
<source/>Hum Mol Genet
          <year>2010</year>
<volume>19</volume>
<fpage>3402</fpage>
<lpage>3412</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddq252</pub-id>
<pub-id pub-id-type="pmid">20584925</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gruner</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cortes-Lopez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>CircRNA accumulation in the aging mouse brain</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>38907</fpage>
<pub-id pub-id-type="doi">10.1038/srep38907</pub-id>
<pub-id pub-id-type="pmid">27958329</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gulino</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Forte</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Parenti</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gulisano</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>TDP-43 as a modulator of synaptic plasticity in a mouse model of spinal Motoneuron degeneration</article-title>
<source/>CNS Neurol Disord Drug Targets
          <year>2015</year>
<volume>14</volume>
<fpage>55</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.2174/1871527314666150116115414</pub-id>
<pub-id pub-id-type="pmid">25613499</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>JU</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bartel</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>Expanded identification and characterization of mammalian circular RNAs</article-title>
<source/>Genome Biol
          <year>2014</year>
<volume>15</volume>
<fpage>409</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-014-0409-z</pub-id>
<pub-id pub-id-type="pmid">25070500</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagihara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Horikawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Umemori</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shoji</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kamitani</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Circadian gene circuitry predicts hyperactive behavior in a mood disorder mouse model</article-title>
<source/>Cell Rep
          <year>2016</year>
<volume>14</volume>
<fpage>2784</fpage>
<lpage>2796</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2016.02.067</pub-id>
<pub-id pub-id-type="pmid">27028761</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Igaz</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Kwong</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Chen-Plotkin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Unger</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Malunda</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Winton</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Trojanowski</surname>
<given-names>JQ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice</article-title>
<source/>J Clin Invest
          <year>2011</year>
<volume>121</volume>
<fpage>726</fpage>
<lpage>738</lpage>
<pub-id pub-id-type="doi">10.1172/JCI44867</pub-id>
<pub-id pub-id-type="pmid">21206091</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jangi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sharp</surname>
<given-names>PA</given-names>
</name>
</person-group>
<article-title>Building robust transcriptomes with master splicing factors</article-title>
<source/>Cell
          <year>2014</year>
<volume>159</volume>
<fpage>487</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2014.09.054</pub-id>
<pub-id pub-id-type="pmid">25417102</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jansen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Giehl</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nyengaard</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lioubinski</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Sjoegaard</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Breiderhoff</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gotthardt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Eilers</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury</article-title>
<source/>Nat Neurosci
          <year>2007</year>
<volume>10</volume>
<fpage>1449</fpage>
<lpage>1457</lpage>
<pub-id pub-id-type="doi">10.1038/nn2000</pub-id>
<pub-id pub-id-type="pmid">17934455</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeck</surname>
<given-names>WR</given-names>
</name>
<name>
<surname>Sorrentino</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Slevin</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Burd</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Marzluff</surname>
<given-names>WF</given-names>
</name>
<name>
<surname>Sharpless</surname>
<given-names>NE</given-names>
</name>
</person-group>
<article-title>Circular RNAs are abundant, conserved, and associated with ALU repeats</article-title>
<source/>RNA
          <year>2013</year>
<volume>19</volume>
<fpage>141</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1261/rna.035667.112</pub-id>
<pub-id pub-id-type="pmid">23249747</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeong</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>SZ</given-names>
</name>
<name>
<surname>Donde</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Braunstein</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Majounie</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Traynor</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>LaClair</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Lloyd</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Tdp-43 cryptic exons are highly variable between cell types</article-title>
<source/>Mol Neurodegener
          <year>2017</year>
<volume>12</volume>
<fpage>13</fpage>
<pub-id pub-id-type="doi">10.1186/s13024-016-0144-x</pub-id>
<pub-id pub-id-type="pmid">28153034</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<mixed-citation publication-type="other">Kaidanovich-Beilin O, Lipina T, Vukobradovic I, Roder J, Woodgett JR (2011) Assessment of social interaction behaviors. J Vis Exp. 10.3791/2473</mixed-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kataoka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamamori</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Miyaoka</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Azuma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ikegami</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kuwahara</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Suzuki-Migishima</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A single amino acid mutation in SNAP-25 induces anxiety-related behavior in mouse</article-title>
<source/>PLoS One
          <year>2011</year>
<volume>6</volume>
<fpage>e25158</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0025158</pub-id>
<pub-id pub-id-type="pmid">21949876</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katz</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Airoldi</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Burge</surname>
<given-names>CB</given-names>
</name>
</person-group>
<article-title>Analysis and design of RNA sequencing experiments for identifying isoform regulation</article-title>
<source/>Nat Methods
          <year>2010</year>
<volume>7</volume>
<fpage>1009</fpage>
<lpage>1015</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.1528</pub-id>
<pub-id pub-id-type="pmid">21057496</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ko</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Ao</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Mendel</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Milbrandt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhuo</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Transcription factor Egr-1 is required for long-term fear memory and anxiety</article-title>
<source/>Sheng Li Xue Bao
          <year>2005</year>
<volume>57</volume>
<fpage>421</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="pmid">16094488</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kushnir</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dresner</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mandel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gozes</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Silencing of the ADNP-family member, ADNP2, results in changes in cellular viability under oxidative stress</article-title>
<source/>J Neurochem
          <year>2008</year>
<volume>105</volume>
<fpage>537</fpage>
<lpage>545</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.05173.x</pub-id>
<pub-id pub-id-type="pmid">18179478</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LaClair</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Donde</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Chhabra</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Depletion of TDP-43 decreases fibril and plaque beta-amyloid and exacerbates neurodegeneration in an Alzheimer's mouse model</article-title>
<source/>Acta Neuropathol
          <year>2016</year>
<volume>132</volume>
<fpage>859</fpage>
<lpage>873</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-016-1637-y</pub-id>
<pub-id pub-id-type="pmid">27785573</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lagier-Tourenne</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cleveland</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Rethinking ALS: the FUS about TDP-43</article-title>
<source/>Cell
          <year>2009</year>
<volume>136</volume>
<fpage>1001</fpage>
<lpage>1004</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2009.03.006</pub-id>
<pub-id pub-id-type="pmid">19303844</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Trojanowski</surname>
<given-names>JQ</given-names>
</name>
</person-group>
<article-title>Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration</article-title>
<source/>Nat Rev Neurosci
          <year>2011</year>
<volume>13</volume>
<fpage>38</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3121</pub-id>
<pub-id pub-id-type="pmid">22127299</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ling</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Pletnikova</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Troncoso</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD</article-title>
<source/>Science
          <year>2015</year>
<volume>349</volume>
<fpage>650</fpage>
<lpage>655</lpage>
<pub-id pub-id-type="doi">10.1126/science.aab0983</pub-id>
<pub-id pub-id-type="pmid">26250685</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ling</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Polymenidou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cleveland</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis</article-title>
<source/>Neuron
          <year>2013</year>
<volume>79</volume>
<fpage>416</fpage>
<lpage>438</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2013.07.033</pub-id>
<pub-id pub-id-type="pmid">23931993</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<mixed-citation publication-type="other">Luscher C, Malenka RC (2012) NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD). Cold Spring Harb Perspect Biol 4. 10.1101/cshperspect.a005710</mixed-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Majumder</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Chatterjee</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Swamy</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>Co-regulation of mRNA translation by TDP-43 and fragile X syndrome protein FMRP</article-title>
<source/>Acta Neuropathol
          <year>2016</year>
<volume>132</volume>
<fpage>721</fpage>
<lpage>738</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-016-1603-8</pub-id>
<pub-id pub-id-type="pmid">27518042</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masana</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Sumaya</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Becker-Andre</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dubocovich</surname>
<given-names>ML</given-names>
</name>
</person-group>
<article-title>Behavioral characterization and modulation of circadian rhythms by light and melatonin in C3H/HeN mice homozygous for the RORbeta knockout</article-title>
<source/>Am J Physiol Regul Integr Comp Physiol
          <year>2007</year>
<volume>292</volume>
<fpage>R2357</fpage>
<lpage>R2367</lpage>
<pub-id pub-id-type="doi">10.1152/ajpregu.00687.2006</pub-id>
<pub-id pub-id-type="pmid">17303680</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyakawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Leiter</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Gerber</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Gainetdinov</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Sotnikova</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Caron</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Tonegawa</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2003</year>
<volume>100</volume>
<fpage>8987</fpage>
<lpage>8992</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1432926100</pub-id>
<pub-id pub-id-type="pmid">12851457</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neary</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Snowden</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Gustafson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Passant</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Stuss</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Freedman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kertesz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Robert</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Albert</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria</article-title>
<source/>Neurology
          <year>1998</year>
<volume>51</volume>
<fpage>1546</fpage>
<lpage>1554</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.51.6.1546</pub-id>
<pub-id pub-id-type="pmid">9855500</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neumann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Igaz</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Kwong</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Nakashima-Yasuda</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kolb</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Dreyfuss</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kretzschmar</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Trojanowski</surname>
<given-names>JQ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>VM</given-names>
</name>
</person-group>
<article-title>Absence of heterogeneous nuclear ribonucleoproteins and survival motor neuron protein in TDP-43 positive inclusions in frontotemporal lobar degeneration</article-title>
<source/>Acta Neuropathol
          <year>2007</year>
<volume>113</volume>
<fpage>543</fpage>
<lpage>548</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-007-0221-x</pub-id>
<pub-id pub-id-type="pmid">17415574</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neumann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sampathu</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Kwong</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Truax</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Micsenyi</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Bruce</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schuck</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Grossman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>CM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis</article-title>
<source/>Science
          <year>2006</year>
<volume>314</volume>
<fpage>130</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="doi">10.1126/science.1134108</pub-id>
<pub-id pub-id-type="pmid">17023659</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ou</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Harrich</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Garcia-Martinez</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Gaynor</surname>
<given-names>RB</given-names>
</name>
</person-group>
<article-title>Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs</article-title>
<source/>J Virol
          <year>1995</year>
<volume>69</volume>
<fpage>3584</fpage>
<lpage>3596</lpage>
<pub-id pub-id-type="pmid">7745706</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perona</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Waters</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>FS</given-names>
</name>
<name>
<surname>Sora</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lesch</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Caron</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Uhl</surname>
<given-names>GR</given-names>
</name>
</person-group>
<article-title>Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions</article-title>
<source/>Behav Pharmacol
          <year>2008</year>
<volume>19</volume>
<fpage>566</fpage>
<lpage>574</lpage>
<pub-id pub-id-type="doi">10.1097/FBP.0b013e32830cd80f</pub-id>
<pub-id pub-id-type="pmid">18690111</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<mixed-citation publication-type="other">Philips T, Rothstein JD (2015) Rodent models of amyotrophic lateral sclerosis. Curr Protoc Pharmacol 69: 5 67 61-21 Doi 10.1002/0471141755.ph0567s69</mixed-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polymenidou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lagier-Tourenne</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hutt</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Huelga</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>TY</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wancewicz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mazur</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43</article-title>
<source/>Nat Neurosci
          <year>2011</year>
<volume>14</volume>
<fpage>459</fpage>
<lpage>468</lpage>
<pub-id pub-id-type="doi">10.1038/nn.2779</pub-id>
<pub-id pub-id-type="pmid">21358643</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prudencio</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Belzil</surname>
<given-names>VV</given-names>
</name>
<name>
<surname>Batra</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Gendron</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Pregent</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Overstreet</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Piazza-Johnston</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Desaro</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS</article-title>
<source/>Nat Neurosci
          <year>2015</year>
<volume>18</volume>
<fpage>1175</fpage>
<lpage>1182</lpage>
<pub-id pub-id-type="doi">10.1038/nn.4065</pub-id>
<pub-id pub-id-type="pmid">26192745</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prudencio</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jansen-West</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Gendron</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>YF</given-names>
</name>
<name>
<surname>Gass</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stuani</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Stetler</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Misregulation of human sortilin splicing leads to the generation of a nonfunctional progranulin receptor</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2012</year>
<volume>109</volume>
<fpage>21510</fpage>
<lpage>21515</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1211577110</pub-id>
<pub-id pub-id-type="pmid">23236149</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rascovsky</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hodges</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Knopman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mendez</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Neuhaus</surname>
<given-names>J</given-names>
</name>
<name>
<surname>van Swieten</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Seelaar</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dopper</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Onyike</surname>
<given-names>CU</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia</article-title>
<source/>Brain
          <year>2011</year>
<volume>134</volume>
<fpage>2456</fpage>
<lpage>2477</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awr179</pub-id>
<pub-id pub-id-type="pmid">21810890</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ratti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Buratti</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins</article-title>
<source/>J Neurochem
          <year>2016</year>
<volume>138</volume>
<issue>Suppl 1</issue>
<fpage>95</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="doi">10.1111/jnc.13625</pub-id>
<pub-id pub-id-type="pmid">27015757</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberson</surname>
<given-names>ED</given-names>
</name>
</person-group>
<article-title>Mouse models of frontotemporal dementia</article-title>
<source/>Ann Neurol
          <year>2012</year>
<volume>72</volume>
<fpage>837</fpage>
<lpage>849</lpage>
<pub-id pub-id-type="doi">10.1002/ana.23722</pub-id>
<pub-id pub-id-type="pmid">23280835</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Smyth</surname>
<given-names>GK</given-names>
</name>
</person-group>
<article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title>
<source/>Bioinformatics
          <year>2010</year>
<volume>26</volume>
<fpage>139</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id>
<pub-id pub-id-type="pmid">19910308</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rybak-Wolf</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stottmeister</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Glazar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jens</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pino</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Giusti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hanan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Behm</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bartok</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Ashwal-Fluss</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed</article-title>
<source/>Mol Cell
          <year>2015</year>
<volume>58</volume>
<fpage>870</fpage>
<lpage>885</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2015.03.027</pub-id>
<pub-id pub-id-type="pmid">25921068</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadakata</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shinoda</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Oka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sekine</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Furuichi</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Autistic-like behavioral phenotypes in a mouse model with copy number variation of the CAPS2/CADPS2 gene</article-title>
<source/>FEBS Lett
          <year>2013</year>
<volume>587</volume>
<fpage>54</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="doi">10.1016/j.febslet.2012.10.047</pub-id>
<pub-id pub-id-type="pmid">23159942</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salzman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gawad</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Lacayo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>PO</given-names>
</name>
</person-group>
<article-title>Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<fpage>e30733</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0030733</pub-id>
<pub-id pub-id-type="pmid">22319583</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scotti</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>RNA mis-splicing in disease</article-title>
<source/>Nat Rev Genet
          <year>2016</year>
<volume>17</volume>
<fpage>19</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1038/nrg.2015.3</pub-id>
<pub-id pub-id-type="pmid">26593421</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shum</surname>
<given-names>FW</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Kaang</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Zhuo</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Genetic alteration of anxiety and stress-like behavior in mice lacking CaMKIV</article-title>
<source/>Mol Pain
          <year>2005</year>
<volume>1</volume>
<fpage>22</fpage>
<pub-id pub-id-type="doi">10.1186/1744-8069-1-22</pub-id>
<pub-id pub-id-type="pmid">16102169</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silverman</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lord</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>Behavioural phenotyping assays for mouse models of autism</article-title>
<source/>Nat Rev Neurosci
          <year>2010</year>
<volume>11</volume>
<fpage>490</fpage>
<lpage>502</lpage>
<pub-id pub-id-type="doi">10.1038/nrn2851</pub-id>
<pub-id pub-id-type="pmid">20559336</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sotrel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>RH</given-names>
</name>
</person-group>
<article-title>Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease: a quantitative Golgi study</article-title>
<source/>Neurology
          <year>1993</year>
<volume>43</volume>
<fpage>2088</fpage>
<lpage>2096</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.43.10.2088</pub-id>
<pub-id pub-id-type="pmid">8413971</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swann</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Al-Noori</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>CL</given-names>
</name>
</person-group>
<article-title>Spine loss and other dendritic abnormalities in epilepsy</article-title>
<source/>Hippocampus
          <year>2000</year>
<volume>10</volume>
<fpage>617</fpage>
<lpage>625</lpage>
<pub-id pub-id-type="doi">10.1002/1098-1063(2000)10:5&lt;617::AID-HIPO13&gt;3.0.CO;2-R</pub-id>
<pub-id pub-id-type="pmid">11075833</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szabo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Salzman</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Detecting circular RNAs: bioinformatic and experimental challenges</article-title>
<source/>Nat Rev Genet
          <year>2016</year>
<volume>17</volume>
<fpage>679</fpage>
<lpage>692</lpage>
<pub-id pub-id-type="doi">10.1038/nrg.2016.114</pub-id>
<pub-id pub-id-type="pmid">27739534</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<mixed-citation publication-type="other">Takao K, Miyakawa T (2006) Light/dark transition test for mice. J Vis Exp 104. 10.3791/104</mixed-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Ke</surname>
<given-names>YD</given-names>
</name>
<name>
<surname>Ittner</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Halliday</surname>
<given-names>GM</given-names>
</name>
</person-group>
<article-title>ALS/FTLD: experimental models and reality</article-title>
<source/>Acta Neuropathol
          <year>2017</year>
<volume>133</volume>
<fpage>177</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-016-1666-6</pub-id>
<pub-id pub-id-type="pmid">28058507</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>RH</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Cleveland</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Decoding ALS: from genes to mechanism</article-title>
<source/>Nature
          <year>2016</year>
<volume>539</volume>
<fpage>197</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1038/nature20413</pub-id>
<pub-id pub-id-type="pmid">27830784</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trapnell</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Goff</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pertea</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Pimentel</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Salzberg</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Rinn</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Pachter</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and cufflinks</article-title>
<source/>Nat Protoc
          <year>2012</year>
<volume>7</volume>
<fpage>562</fpage>
<lpage>578</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2012.016</pub-id>
<pub-id pub-id-type="pmid">22383036</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Chien</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>CK</given-names>
</name>
</person-group>
<article-title>Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U</article-title>
<source/>J Exp Med
          <year>2010</year>
<volume>207</volume>
<fpage>1661</fpage>
<lpage>1673</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20092164</pub-id>
<pub-id pub-id-type="pmid">20660618</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsien</surname>
<given-names>JZ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Gerber</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tom</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mercer</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Mayford</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kandel</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Tonegawa</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Subregion- and cell type-restricted gene knockout in mouse brain</article-title>
<source/>Cell
          <year>1996</year>
<volume>87</volume>
<fpage>1317</fpage>
<lpage>1326</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)81826-7</pub-id>
<pub-id pub-id-type="pmid">8980237</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Mossevelde</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Engelborghs</surname>
<given-names>S</given-names>
</name>
<name>
<surname>van der Zee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Van Broeckhoven</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Genotype-phenotype links in frontotemporal lobar degeneration</article-title>
<source/>Nat Rev Neurol
          <year>2018</year>
<volume>14</volume>
<fpage>363</fpage>
<lpage>378</lpage>
<pub-id pub-id-type="doi">10.1038/s41582-018-0009-8</pub-id>
<pub-id pub-id-type="pmid">29777184</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vorhees</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>MT</given-names>
</name>
</person-group>
<article-title>Morris water maze: procedures for assessing spatial and related forms of learning and memory</article-title>
<source/>Nat Protoc
          <year>2006</year>
<volume>1</volume>
<fpage>848</fpage>
<lpage>858</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2006.116</pub-id>
<pub-id pub-id-type="pmid">17406317</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>IF</given-names>
</name>
<name>
<surname>Bose</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>CK</given-names>
</name>
</person-group>
<article-title>Structural diversity and functional implications of the eukaryotic TDP gene family</article-title>
<source/>Genomics
          <year>2004</year>
<volume>83</volume>
<fpage>130</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1016/S0888-7543(03)00214-3</pub-id>
<pub-id pub-id-type="pmid">14667816</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>IF</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>CK</given-names>
</name>
</person-group>
<article-title>TDP-43: an emerging new player in neurodegenerative diseases</article-title>
<source/>Trends Mol Med
          <year>2008</year>
<volume>14</volume>
<fpage>479</fpage>
<lpage>485</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2008.09.001</pub-id>
<pub-id pub-id-type="pmid">18929508</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yee</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Dinneny</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>PO</given-names>
</name>
<name>
<surname>Salzman</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Circular RNA is expressed across the eukaryotic tree of life</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<fpage>e90859</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0090859</pub-id>
<pub-id pub-id-type="pmid">24609083</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Welch</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rodriguiz</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Trotta</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Peca</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Feliciano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice</article-title>
<source/>Nature
          <year>2007</year>
<volume>448</volume>
<fpage>894</fpage>
<lpage>900</lpage>
<pub-id pub-id-type="doi">10.1038/nature06104</pub-id>
<pub-id pub-id-type="pmid">17713528</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>White</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Duffy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Adalbert</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>BU</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>OM</given-names>
</name>
<name>
<surname>Stephenson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Massenzio</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD</article-title>
<source/>Nat Neurosci
          <year>2018</year>
<volume>21</volume>
<fpage>552</fpage>
<lpage>563</lpage>
<pub-id pub-id-type="doi">10.1038/s41593-018-0113-5</pub-id>
<pub-id pub-id-type="pmid">29556029</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willnow</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Nykjaer</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>VPS10P-domain receptors - regulators of neuronal viability and function</article-title>
<source/>Nat Rev Neurosci
          <year>2008</year>
<volume>9</volume>
<fpage>899</fpage>
<lpage>909</lpage>
<pub-id pub-id-type="doi">10.1038/nrn2516</pub-id>
<pub-id pub-id-type="pmid">19002190</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>CK</given-names>
</name>
</person-group>
<article-title>TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis</article-title>
<source/>Genesis
          <year>2010</year>
<volume>48</volume>
<fpage>56</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1002/dvg.20584</pub-id>
<pub-id pub-id-type="pmid">20014337</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>CK</given-names>
</name>
</person-group>
<article-title>Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice</article-title>
<source/>J Biol Chem
          <year>2012</year>
<volume>287</volume>
<fpage>27335</fpage>
<lpage>27344</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M112.359000</pub-id>
<pub-id pub-id-type="pmid">22718760</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Coats</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>OM</given-names>
</name>
<name>
<surname>Alvarado</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Izumi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>NM</given-names>
</name>
</person-group>
<article-title>Modular genetic control of sexually dimorphic behaviors</article-title>
<source/>Cell
          <year>2012</year>
<volume>148</volume>
<fpage>596</fpage>
<lpage>607</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2011.12.018</pub-id>
<pub-id pub-id-type="pmid">22304924</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<mixed-citation publication-type="other">Yang C, Wang H, Qiao T, Yang B, Aliaga L, Qiu L, Tan W, Salameh J, McKenna-Yasek DM, Smith T et al (2014) Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 111: E1121–E1129 10.1073/pnas.1322641111</mixed-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>You</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Vlatkovic</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Babic</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Will</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tushev</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Akbalik</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Glock</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Quedenau</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity</article-title>
<source/>Nat Neurosci
          <year>2015</year>
<volume>18</volume>
<fpage>603</fpage>
<lpage>610</lpage>
<pub-id pub-id-type="doi">10.1038/nn.3975</pub-id>
<pub-id pub-id-type="pmid">25714049</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zamanian</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Foo</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Nouri</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Giffard</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Genomic analysis of reactive astrogliosis</article-title>
<source/>J Neurosci
          <year>2012</year>
<volume>32</volume>
<fpage>6391</fpage>
<lpage>6410</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.6221-11.2012</pub-id>
<pub-id pub-id-type="pmid">22553043</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>A comprehensive overview and evaluation of circular RNA detection tools</article-title>
<source/>PLoS Comput Biol
          <year>2017</year>
<volume>13</volume>
<fpage>e1005420</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1005420</pub-id>
<pub-id pub-id-type="pmid">28594838</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Seabold</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Horak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Petralia</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>MAGUKs, synaptic development, and synaptic plasticity</article-title>
<source/>Neuroscientist
          <year>2011</year>
<volume>17</volume>
<fpage>493</fpage>
<lpage>512</lpage>
<pub-id pub-id-type="doi">10.1177/1073858410386384</pub-id>
<pub-id pub-id-type="pmid">21498811</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>